• Author Index
• Abstract Index
• Subject Index
• Search
• Journal Homepage
• ISTH Homepage
• Online Journal
• Privacy Policy
• 2003
• 2005
• 2007
• 2009

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

C
Cabrera-Espinós E.	-	Platelet–erythrocyte interactions enhance GPIIbIIIa receptor activation and P-selectin expression during platelet recruitment. These effects are amplified in type I diabetic patients
Cabrio L.	-	A frequent, apparently silent, polymorphism in prekallikrein (Fletcher factor) gene
	-	Factor VII deficiency associated with severe hemophilia A
Caen J.	-	Defective vWF–Fibrin–GPIb interaction causes impaired prothrombin consumption in Bernard–Soulier Syndrome
Cafferata T.	-	Reducing body iron stores lowers inflammatory cytokine levels in atherosclerotic claudicants
Cagney G.	-	Proteomic analysis of proteins secreted by platelets
Cahill D. J.	-	Proteomic analysis of proteins secreted by platelets
	-	Identification of an integrin-associated chloride channel in human platelets
Cai W.	-	Identification of two novel point mutations in XIII A chain gene associated with congenital deficiency in a Chinese FXIII deficiency family
Cai S.	-	Platelet activation and platelet VASP phosphorylation in mice with streptozotocin-induced diabetes mellitus – association with endothelial dysfunction and reduced nitric oxide bioactivity
Caiafa J.	-	Cost analysis of the treatment of patients with post–thrombotic syndrome in Brazil
Cailleux N.	-	Bilateral deep-vein thrombosis and cancer: prospective study of 103 patients
	-	Frequency and effects of cytochrome P450 2C9 polymorphisms in 61 patients treated by warfarin
	-	Prethrombotic biological markers in congenital thrombophilic patients. Preliminary results of a randomized long-term secondary prophylaxis study using warfarin and comparing two INR target ranges
Caine G.	-	Increased platelet adhesion in metastatic cancer
	-	Plasma P selectin must be measured in a citrated sample, not in serum
	-	Platelet, coagulation and endothelial markers in primary thrombocythaemia
Cal P.	-	A novel method of measuring fibrinopeptide B for the detection of venous thromboembolism
Calatzis A.	-	Rapid and automated quantification of the kinetics of thrombin formation using the Thrombin Dynamics Test (TDT)
	-	Improved differentiation between factor V wild type and factor V Leiden patients using a new prothrombin-based activated protein C resistance assay
Calderwood D.	-	The scaffold function of b3 integrins regulates integrin signaling
Callahan K. S.	-	Inflammatory modulation of alveolar coagulation inhibition in a mouse model of acute respiratory distress syndrome (ARDS)
Callas P. W.	-	Lower degree of protein C activation in protein C deficient individuals of a large kindred with type I PC deficiency, as measured by the level of APC-PCI complex
	-	Heritability of clotting factors and the prothrombotic state: results from a large thrombophilic pedigree of French Canadian descent with Type I protein C deficiency
Callas P.	-	Quality of life and risk perception in a large family with heritable protein C deficiency (IPCI: International Protein C Investigation)
	-	Asymptomatic venous thrombosis is a frequent event in protein C deficiency: a systematic ultrasound assessment of 208 family members with the 3363-C insertion mutation (IPCI: International Protein C Investigation)
Calvez T.	-	Effect of type of treatment (recombinant vs. plasmatic) on FVIII inhibitor incidence according to known risk cofactors in previously untreated severe hemophilia A patients (Pups)
Calvo J.	-	Circulating activated protein C in Behcet's disease and risk of thrombosis
Camargo E. C. S.	-	Inherited prothrombotic risk factors in a Brazilian cohort with CVT
	-	Acquired prothrombotic-associated factors in cerebral venous thrombosis (CVT)
Cambien B.	-	Anti-thrombotic effects of tumor necrosis factor-a
Cambien F.	-	Functional studies of P-selectin polymorphism's associated with coronary diseases
Cambus J. P.	-	In terms of clinical impact, thromboplastins with an ISI close to 1 yield better results than thromboplastins with an ISI close to 2, in an external quality control campaign
Camera M.	-	Platelet-associated Tissue Factor: modulation of cell surface expression by platelet agonists
Camera M.	-	Platelet-associated Tissue Factor expression in patients with unstable coronary artery disease
Cameron C.	-	An ancient von Willebrand Disease (VWD) mutation that associates with a common haplotype in ~14% of type 1 VWD patients
Cameron J.	-	Point-of-care testing shows clinically relevant variation in the degree of inhibition of platelets by standard dose abciximab therapy during percutaneous coronary intervention
Cameron C. L.	-	Clear familial co-segregation of the type 1 von Willebrand disease phenotype and VWF haplotypes in the Canadian type 1 VWD study
	-	The type 1/type 2M von Willebrand disease dilemma: findings from the Canadian Type 1 VWD study
Camilleri R. S.	-	A proposed ISTH revised classification for the anti-phospholipid syndrome
Camilleri R.	-	Reduction in stillbirth and IUGR with aspirin +/- low molecular weight heparin treatment in pregnancy
Camilleri R.	-	Venous thromboembolism and the -455G/Ab-fibrinogen gene polymorphism
Camilleri R. S.	-	Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (beta2GPI) polymorphism and antibeta2GPI antibodies
Camire R. M.	-	Impaired prothrombinase activity of Factor X Gly381Asp results in severe familial CRM + FX deficiency
Camire R.	-	A transgenic mouse model demonstrates the efficacy of Factor VIII ectopically expressed in platelets for Haemophilia A treatment
Camoin-Jau L.	-	Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth retardation
Camoin-Jau L.	-	Evaluation of aspirin resistance by platelet function analyzer (PFA-100™) in patients with acute coronary syndrome®
	-	Interest of VASP measurement on patients treated by thienopyridines
Campbell J.	-	Prospective cohort study of paediatric venous thrombosis
Campbell K.	-	Platelet CD109: evidence for a transmembrane homologue on monocytes?
Campbell J.	-	Thrombolytic therapy with tissue plasminogen activator (tPA), analysis of safety and outcome in children
	-	Arterial thromboembolic disease in infants and children
Campbell K.	-	Teicoplanin-dependent platelet antibodies as a cause of severe thrombocytopenia
Campbell J.	-	Reference ranges for hemostatic parameters in children
	-	Anti-coagulation clinics for children achieve improved warfarin management
Campbell K.	-	The epitope of the CD109 monoclonal antibody 8A3 overlaps with the epitope of Gov antibodies: implications for Gov antibody detection
Campolo J.	-	Blood glutathione detects pro-oxidant patterns in mild hyperhomocysteinemia associated with atherothrombotic vascular events
Campolo J.	-	A new preanalytical procedure using dried blood spot sample for total homocysteine determination
Camporese G.	-	Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study
	-	Correlation between internal carotid artery stenosis and hematological risk factors for thrombosis (CAST study): final results
Camporese G.	-	Management of hospitalized patients with suspected deep vein thrombosis
Campos M.	-	Coagulation inhibitor monitoring rationale in critical patients with severe sepsis
	-	The prognostic value of platelet count drop in an intensive care unit
	-	Molecular basis of inherited anti-thrombin deficiency in Portuguese families: identification of underlying molecular defects and screening for additional thrombotic risk factors
	-	Glanzmann thrombasthenia: a study of two Portuguese families and identification of a new homozygous C insertion in exon 10 of the GPIIIa
Can U.	-	Thrombotic risk factors in stroke patients
Canaleta C.	-	Evaluation of HaemosIL HS-CRP. A new latex immunoassay to quantitatively determine C-Reactive Protein (CRP) in citrated plasma, totally automated on coagulation analysers
Canault M.	-	Transmembrane TNFa and wild-type TNFa differently modulate atherosclerotic process in mice
Canciani M. T.	-	New automated von Willebrand factor activity assay to distinguish type 1 and type 2 von Willebrand disease (VWD)
	-	Platelet integrin a2 SNP 807C is a predictor of bleeding in Von Willebrand Disease (VWD) type 1
	-	In vitro expression study of four single nucleotide polymorphisms in the ADAMTS13 gene
	-	Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS-13 von Willebrand factor cleaving protease)
	-	In vitro expression study of two naturally occurring mutations (D141Y and C275S) of the von Willebrand factor (VWF) proeptide that result in defective multimerization and secretion
Candea M. C.	-	Use of recombinant activated factor VII (NovoSeven) in patients with liver cirrhosis
Cangemi R.	-	Fibrinogen as predictor of ischemic stroke in patients with nonvalvular atrial fibrillation
Cannata R.	-	High prevalence of aspirin resistance in patients with a history of myocardial infarction
Cannon C. P.	-	Combination therapy with low-molecular weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)
	-	Combination therapy with low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)
Canobbio I.	-	Activation of p38 MAP kinase in human platelets stimulated by von Willebrand factor
Canonico V.	-	Impairment of fibrynolytic capacity in experimentally induced ketoacidosis in continuous subcutaneous insulin infusion patients
Cantillon C.E.	-	The Veterans Affairs Cooperative Studies Program's ‘80+ Hemorrhagic Cohort Study
Canton M.	-	Standardization of circulating endothelial cell enumeration in whole blood
Canu P.	-	Lagrangian modeling of platelet adhesion and its application to experimental data
Cao D. J.	-	Apoptotic effect of cleaved high molecular weight kininogen is selectively regulated by extracellular matrix proteins
Cao H.	-	Improvements in flow measurements of fibrin network permeation in plasma or purified fibrinogen-thrombin system
Capani F.	-	Hyperhomocysteinemia is associated with the progression of peripheral arterial disease in type 2 diabetic patients
Capasso M.	-	The impact of intravenous heparin administration on duration of hospitalization
Capasso F.	-	Transdermal hormone replacement therapy does not affect hemostasis and inflammation
Capdevila A.	-	Two sensitive chromogenic assays of fondaparinux sodium (Arixtra®), a new synthetic and selective inhibitor of factor Xa, in plasma
Capiod T.	-	A new evidence of a relationship between store-operated calcium entry and the regulation of procoagulant phosphatidylserine exposure at the surface of stimulated cells
Capmany C.	-	Preconceptional and gestational enoxaparin regimes adjusted to fertility program to prevent preclinical, embryonic and fetal loss in women with Recurrent Pregnancy Loss (RPL) and thrombophilia
Cappelletti A.	-	Clinical presentation of type 1 von Willebrand disease (VWD) in obligatory carriers: final results from a collaborative, international, multicenter study
	-	Comparison of hemorrhagic symptoms in obligatory carriers of type 1 and type 3 von willebrand disease (VWD): results from a collaborative, international, multicenter study
Cappi C.	-	Elevated plasma levels of factor VIII in women with early recurrent miscarriage
	-	Reduced platelet sensitivity to nitric oxide donors in patients with a history of preeclampsia
Cappucci F.	-	Prevalence of haemostatic abnormalities in women with 3 or more implantation failures after in vitro fertilization
	-	FV plasma levels and the activated protein C resistance phenotype are modulated by the FV gene Asp79His polymorphism in presence of the FV Leiden mutation
Capraru M.	-	Effects of enoxaparin on high glucose induced activation of human endothelial cells
Caprini J. A.	-	Thrombosis risk factor assessment in surgical patients: compliance with chest consensus guidelines
Caprini J. A.	-	Use of umbilical cord vein in an in vitro perfusion model to study blood-borne metastasis
Caprini J. A.	-	Report from the studies on prevention: Extended travel
	-	Cost-effectiveness of venous thromboembolism prophylaxis after total hip replacement
	-	Thrombosis prophylaxis following total hip replacement
Capussotti L.	-	A clinical outcome-based prospective study on venous thromboembolism in cancer surgery: the @RISTOS project
Carandina S.	-	The G>T point mutation (Val34Leu) in the Factor XIII-A subunit gene in venous leg ulcers
Carballo G. A.	-	Von Willebrand factor cleaving protease (VWFCP) activity in patients with pre-eclampsia history: preliminary results
Carballo G. A.	-	Comparative study of conformation sensitive gel electrophoresis and DNA sequencing for polymorphisms and mutation detection in von Willebrand disease type 2 N
Carballo G. A.	-	Virtual decrease of von Willebrand Factor-cleaving protease (ADAMTS13) after infusion of desmopressin (DDAVP)
	-	Control of von Willebrand factor multimer size by a fibronectin related substance
Carcao M.	-	Central venous catheter (CVC) related thrombosis in boys with hemophilia
Carcao M.	-	Central venous catheter-related thrombosis presenting as SVC syndrome in a hemophiliac with inhibitors
Carcillo J.	-	Protein C activation and possible use in different disease states - Multi-organ failure and underlying thrombocytopenia
Cardaropoli S.	-	Intruterine Growth Restriction (IUGR) and thrombophilic polymorphisms
Cardin A. D.	-	Intimatan ameliorates the activation of human platelets by heparin/heparin antibody from patients with heparin-induced thrombocytopenia
	-	Pharmacodynamic profile of Intimatan as an antithrombotic agent for venous thrombosis
Cardos L. F.	-	Analysis of the effectiveness of the D-Dimer test to exclude acute venous thromboembolism
Cardoso-Saldaña G.	-	Lipoprotein (a) polymorphisms in Mexican-Amerindian populations
Carelli G.	-	Anti-thrombotic effect of combination of low molecular weight heparin with low doses of unfractionated heparin in experimental venous thrombosis
Carew J. A.	-	Polymorphisms of the factor VII gene and ischemic stroke in young adults
Cariou R. G.	-	Fondaparinux vs. placebo for the prevention of venous thromboembolism in acutely ill medical patients (artemis)
Carlier E.	-	The biphasic waveform of APTT optical clot formation profile is related with the activation of FVII but not with ISTH DIC score or classical coagulation activation parameters
Carlin K.	-	The cytoplasmic domain of tissue factor plays an important role in innate and adaptive immunity
Carloni M. T.	-	Recombinant activated Factor VII (rFVIIa) for the treatment of bleeding secondary to acquired factor VIII inhibitor
Carlson M.	-	A comparative in vitro evaluation of seven von Willebrand factor concentrates
	-	Evaluation of an automated assay for rapid analysis of von Willebrand ristocetin cofactor activity
Carlsson S.	-	Dose-dependent inhibition of thrombosis by melagatran in a nonhuman primate model
Carlsson L.	-	Expression and function of platelet glycoproteins in newborns and adults
Carlsson L. E.	-	The impact of GPIIb-IIIa and GPIa-IIa polymorphisms on the adhesion of platelets to collagen and fibrinogen in a microtiter-plate adhesion system under static and dynamic conditions
Carlsson S.	-	Experience of using FEIBA™ to attenuate the effects of anticoagulation on inhibition of thrombogenesis in primates
Carluccio M.	-	NAD(P)H oxidase C242T gene variations and cardiovascular protection
Carluccio M. A.	-	Statins inhibit cyclo-oxygenase (cox)-2 and metalloproteinase (mmp)-9 expression in human endothelial cells: possible contribution to plaque stability
Carmeliet P.	-	The cytoplasmic domain of tissue factor plays an important role in innate and adaptive immunity
Carmeliet P.	-	Novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders
Carmeliet P.	-	The cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia
	-	Plasminogen activator inhibitor type I-deficient (PAI–/–) mice show an improved early host defense in E. coli peritonitis by a neutrophil-dependent mechanism
	-	Plasminogen activator inhibitor type I-deficient (PAI–/–) mice show an improved early host defense in E. coli peritonitis by a neutrophil-dependent mechanism
	-	Effect of anticoagulants with various modes of action on thrombin generation in plasma of mice with targeted Arg47-to-Cys mutation of the heparin-binding domain of antithrombin
	-	Deficiency in one Gas6 receptor (Axl, Sky or Mer) protects mice against thrombosis because of a platelet dysfunction
Carmena R.	-	Platelet–erythrocyte interactions enhance GPIIbIIIa receptor activation and P-selectin expression during platelet recruitment. These effects are amplified in type I diabetic patients
Carmona F.	-	Effect of antiphospholipid antibodies in the activation of the contact complex: importance in the obstetric complications of the antipospholipid syndrome
Carnaghi L.	-	Tissue factor and tissue factor pathway inhibitor expression by adherent monocytes and alveolar macrophages
Carneiro J.	-	Venous thromboembolism (VTE) in children: a series of cases from a pediatric Brazilian cohort
Carnovali M.	-	Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism
Caron C.	-	Analytical validation of the automated measurement on STA-R of the ristocetin cofactor activity (VWF:RCo) of von Willebrand factor
Caron C.	-	Evaluation of automated measurement of ristocetin cofactor activity of von Willebrand factor on STA-R® in von willebrand disease: study in 154 patients
Caron N.	-	A modified ELISA procedure for platelet factor 4 with decreased heparin sensitivity
Caron C.	-	Interest of diluted Russel viper venom time (dRVVT) in determining “pathogenic” lupus anticoagulants
	-	Type 2N von Willebrand disease due to compound heterozygosity for the frequent R854Q type 2N mutation and a new R763G mutation abolishing the cleavage of von Willebrand factor propeptide
Carp H.	-	Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study
Carr M.	-	Therapeutic monitoring of bleeding disorders: The RoTeg method
Carraro G.	-	Plasma fibrinolytic capacity and 4G/5G polymorphism of PAI-1 gene in heart and kidney transplant recipients with or without steroid immunosuppression
	-	Anti-prothrombin antibodies in patients with recurrent venous thromboembolism
Carre E.	-	Anti-thrombotic treatment after coronary artery bypass graft surgery (CABGS):economic consequence of a change in regimen
Carrell R. W.	-	Measurement of the in-vitro half life and the pathological significance of the transition of anti-thrombin to the latent state
	-	Conformational basis of homozygous heparin cofactor II deficiency confirms critical role of P17 glutamate in serpins
	-	Mutations in the shutter region of anti-thrombin result in severe episodic thrombosis and unlike other serpins in formation of disulfide-linked dimers
Carrier M.	-	Functional protein S testing does not exclude protein S deficiency
Soria J.M.	-	Genetic coregulation of C4b-binding protein (C4BP) and free Protein S plasma levels: a link between complement and hemostasis
Carroll J.	-	Unexpected pattern of hypercoagulable states in patients with patent foramen ovale (PFO) or atrial septal defect (ASD) and neurological events
Carson P. J.	-	A program for the point of care testing (POCT) of the ACT to ensure safe control of heparinization in coronary angioplasty
Carteaux J. P.	-	The thrombin potential in contrast to clotting times is only slightly modified after uncomplicated heart valve replacement in adults
Carter A. M.	-	P-selectin polymorphisms: their relationship to soluble P-selectin levels and cardiovascular risk
Carter N.	-	Enhanced thrombus recanalization and resolution after vascular endothelial growth factor (VEGF) naked DNA gene transfer
Carter A. M.	-	Complement C3 and its relationship to features of the insulin resistance syndrome and cardiovascular disease
	-	The influence of metformin on markers of inflammation in subjects with type 2 diabetes mellitus: evidence to support the common soil hypothesis
Carter A. M.	-	Plasma leptin is associated with hemostatic cardiovascular risk factors
	-	b3 integrin haplotype influences gene regulation
	-	The effect of factor XIII Val34Leu on clot structure is fibrinogen dependent: evidence for a mechanism for cardioprotection of the Leu allele at high fibrinogen levels
Cartwright I.	-	Use of plasma spiked with monoclonal antibodies in lupus anticoagulant (LA) screening; experience with the UK NEQAS (Blood Coagulation) proficiency testing program
Caruso A.	-	The G>T point mutation (Val34Leu) in the Factor XIII-A subunit gene in venous leg ulcers
Caruso R.	-	Blood glutathione detects pro-oxidant patterns in mild hyperhomocysteinemia associated with atherothrombotic vascular events
Caruso A.	-	Inherited thrombophilia and associated risk for unexplained fetal loss
Caruso R.	-	A new preanalytical procedure using dried blood spot sample for total homocysteine determination
Carvalhais A.	-	Temporary discontinuation of oral anti-coagulants in oncologic patients with mechanical heart valves
Carvalho M. G.	-	Markers of hypercoagulability in Brazilian patients with DVT undergoing oral anti-coagulation therapy
Carvalho L. C.	-	Anti-thrombotic effect of combination of low molecular weight heparin with low doses of unfractionated heparin in experimental venous thrombosis
Carvalho M. G.	-	Hemostatic parameters in Brazilian asymptomatic carriers of Factor V Leiden, prothrombin (G20210A) and methylenetetrahydrofolate reductase (C677T) mutations
Casaña P.	-	Detection the 3614 G > A (R1205H) mutation in the VWF gene in 26 Spanish patients with high penetrance dominant type 1 von Willebrand disease
Casademunt E.	-	A novel recombinant factor VIII produced by a human cell line functionally restores coagulation deficits in a mouse model of hemophilia A
Casais P.	-	Prevalence of haemostatic and fibrinolytic abnormalities in women with unexplained embryofetal losses and vascular obstetric complications
	-	Cysteine–homocysteine ratio in patients with C677T mutation of the MTHFR gene
Casais P.	-	Anti-phospholipid antibodies and hyperhomocysteinemia: response to therapy with folic acid
Casais P.	-	Anticoagulation therapy outcome in children after extracardiac conduit Fontan operation
	-	Low molecular weight heparin (LMWH) in pregnant women with mechanical prosthetic heart valves (MPHV)
Casali A.	-	Hyperhomocysteinemia and other thrombophilic factors in Italian patients with inflammatory bowel disease
Casanegra A.	-	Co-prescription of drugs with potential interaction with oral anti-coagulants in a health maintenance system from Córdoba, Argentina
Casani L.	-	Local blockade of vWF binding epitopes on damaged vessel wall exposed collagen with Saratin inhibits thrombotic risk at different hemodynamic conditions
	-	Local blockade of the collagen binding domain to vWF-A3 with Saratin decreases thrombotic risk in human atherosclerotic lesions
Casanova J. R.	-	Regulation of coagulation factor VII expression in dermal fibroblasts by serum and growth factors
	-	Extrahepatic synthesis of coagulation factor VII in prostate and breast cancer
Casazza F.	-	Long-term clinical outcome of patients with pulmonary embolism: a prospective, multicenter study
	-	Incidence of newly diagnosed cancer after three months or one year of oral anticoagulation for a first episode of idiopathic venous thromboembolism
Casei M.	-	Safety considerations of Enoxaparin as an alternative to oral anti-coagulants in high risk cardioembolic patients with a programed surgical procedure. SWITCH trial
Casetta B.	-	A proteomic approach to identify plasma lipoprotein-associated proteins with a potential role in atherothrombosis
Casey B.	-	Severe factor VII deficiency caused by a new point mutation combined with a previously undetected gene deletion
Casonato A.	-	Interaction of factor VIII and von Willebrand factor investigated in a large cohort of von Willebrand disease patients: evaluation of the type 2N variant prevalence
	-	Type Vicenza Arg1205His mutation alone induces reduction in the level and survival of von Willebrand factor
Cassar K.	-	Enhanced in vivo platelet activation in patients with peripheral arterial disease, and differences between intermittent claudication and critical limb ischemia
Cassar K.	-	The CAVA study: a double-blind randomized controlled trial of clopidogrel and aspirin vs. aspirin alone in patients with intermittent claudication undergoing peripheral percutaneous transluminal angioplasty
Cassara J.	-	Acquired von Willebrand's disease not responding to Rituximab
Cassim N.	-	HIV associated thrombocytopenia: a 3-year trend analysis at the Johannesburg Hospital
Cast L.	-	Tissue factor activity is controlled by its inhibitor and redox state: Findings in endothelial microparticles, monocytes, and a porcine trauma model
Castaman G.	-	Sensitivity and specificity of PFA-100® vs. bleeding time in the diagnosis of type 1 von Willebrand disease (VWD)
Castaman G.	-	Molecular and clinical markers for the diagnosis and management of type 1 von Willebrand's disease (VWD): The progress of a European collaboration
	-	Mutation analysis in type 1 von Willebrand disease patients entered in the multicenter MCMDM-1VWD study
Castaman G.	-	The Factor V HR2 haplotype and the risk of venous thrombosis: a metanalysis
	-	Clinical presentation of type 1 von Willebrand disease (VWD) in obligatory carriers: final results from a collaborative, international, multicenter study
Castaman G.	-	Risk for recurrent venous thromboembolism among patients with severe inherited thrombophilia
	-	An improved multimeric analysis identifies a subgroup of patients with Type 1 von Willebrand disease characterized by reduced VWF:RCo/Ag ratio
	-	In vitro expression of 4 novel mutations identified in type 1 von Willebrand disease patients
	-	Comparison of hemorrhagic symptoms in obligatory carriers of type 1 and type 3 von willebrand disease (VWD): results from a collaborative, international, multicenter study
	-	PROSIT: functional analysis of identified PROS1gene mutations
	-	Co-segregation of Von Willebrands disease type 1 phenotype and Von Willebrand factor gene haplotypes: first results from the multicenter study molecular and clinical markers for the diagnosis and management of type 1 Von Willebrands disease
	-	Genetically defined protein S (PS) deficiency is associated with venous thrombosis
	-	Evaluation of a new quantitative, rapid test (VWF-LIA) for the diagnosis of type 1 VWD
	-	Contribution of factor V deficiency to the thrombotic risk associated with factor V HR2
Castaman G.	-	Plasma-derived FXIII concentrate is as safe and effective as placenta-derived FXIII concentrate for the treatment of inherited FXIII deficiency
Castaman G.	-	Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues
Castaneda S.	-	The PAI-1 and tPA concentrations in patients with classic homocystinuria
	-	The homocysteine, PAI-1 and tPA concentration ratio status: a thrombogenic link in classic homocystinuria
Castedo G.	-	High levels of factors VIII, IX and XI in patients with a thromboembolic event
Castellani S.	-	Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal transplant recipients
Castellanos Y.	-	A postoperative platelet count threshold contributes to an earlier diagnosis of heparin-induced thrombocytopenia and improved platelet recovery in cardiac surgery patients. The HITME (Heparin-Induced Thrombocytopenia Multicenter Evaluation) study
Castellino F. J.	-	Examining the role of coagulation Factor VII using FVII-insufficient mice
Castellino F.	-	In vivo activated protein C (APC) neuroprotective activity involves endothelial protein C receptor (EPCR) and protease activated receptor 1 (PAR-1)
Castelló R.	-	Quantitative real-time gene expression analysis for several components of fibrinolytic and matrix metalloproteinase systems in primary breast cancer
Castelló R.	-	Lipoprotein (a) levels and isoforms and fibrinolytic parameters in young survivors of myocardial infarction with and without peripheral artery disease
	-	Quantitative real-time reverse transcription-PCR (RT-PCR) assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1 and tissue metalloproteinase inhibitor type 1 gene expression and protein levels in endometriosis
Castelo-Branco S.	-	Effects of cardiopulmonary bypass on platelet activation markers
Castilla Llorente C.	-	Massive life-threatening lung hemorrhage and successful treatment with recombinant human-activated FVIIa concentrates
Castillo R.	-	Comparison of hemorrhagic symptoms in obligatory carriers of type 1 and type 3 von willebrand disease (VWD): results from a collaborative, international, multicenter study
	-	Clinical presentation of type 1 von Willebrand disease (VWD) in obligatory carriers: final results from a collaborative, international, multicenter study
Castoldi E.	-	Enhanced thrombin generation and mild bleeding tendency in a severely FVII-deficient patient carrying FV Leiden
Castoldi E.	-	Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool
Castoldi E.	-	Impaired anticoagulant activity of factor V accounts for a large fraction of the APC resistance associated with the FV Leiden (R506Q) and R2 (H1299R) mutations
Castori I.	-	Interaction between thrombophilic genetic mutations and clinical bleeding in patients undergoing chronic oral anti-coagulant treatment
Castori L.	-	Genetically defined protein S (PS) deficiency is associated with venous thrombosis
	-	Prevalence of thrombophilic genetic mutations in patients undergoing thrombotic events while on oral anticoagulants: a case-control study
Caswell M.	-	Sibling stem cell transplant to cure Bernard Soulier Syndrome
Catalfamo J. L.	-	Statin regulation of extrinsic thrombin generation
Cate H.	-	Coagulation abnormalities in dengue virus infections: more common than currently perceived?
Catrix M.	-	Influence of cytochrome P450 2C9 polymorphisms on warfarin maintenance dose in very elderly patients
Cattabiani L.	-	1286 prospective consecutive cases of venous thromboembolic disease at the single venous thromboembolic Unit of Reggio Emilia
Cattaneo M.	-	Does plasma homocysteine influence the in vitro anti-coagulant response to activated Protein C?
Cattaneo M.	-	Concomitant activation of both the P2Y1-driven Gq and the P2Y12-driven Gi pathways is necessary for normal ADP-induced mobilization of platelet cytoplasmic Ca2+
	-	The P2X1 receptor for ATP plays an essential role in platelet aggregation at high shear
Cattaneo M.	-	A key role of the fast ATP-gated P2X1 cation channel in the thrombosis of small arteries in vivo
	-	A key role of the fast ATP-gated P2 X 1 cation channel in the thrombosis of small arteries in vivo
	-	Homocysteine lowering by B vitamins and the prevention of secondary deep-vein thrombosis and pulmonary embolism: a randomized, placebo-controlled, double-blind trial
Cattaneo M.	-	Inherited platelet-based bleeding disorders
Cattini M. G.	-	Type Vicenza Arg1205His mutation alone induces reduction in the level and survival of von Willebrand factor
Catto A. J.	-	Increased coagulation factor XIII B subunit antigen and factor XIII biotin activity is associated with family history of stroke in South Asians
	-	Increased factor XIII B and decreased factor XIII A subunit antigen levels in insulin resistant South Asian patients with ischaemic stroke
Cauchie P.	-	The biphasic waveform of APTT optical clot formation profile is related with the activation of FVII but not with ISTH DIC score or classical coagulation activation parameters
	-	A new Global Plasma Fibrinolytic Assay for the rapid analysis of hyper-/hypo-Fibrinolysis: relationship with blood lipids and inflammatory markers
Caughey R. C.	-	Recombinant FVIIa promotes adhesion and aggregation of platelets in normal subjects and von Willebrand disease patients as measured in the PFA100™
Cauli C.	-	G20210A prothrombin mutation and factor V Leiden (G1691A) to address local health policy
	-	G20210A prothrombin mutation and allele 4G of gene PAI-1 in deep vein thrombosis
Caulin C.	-	Early prediction of the sensitivity of warfarin in elderly patients by the fall in factor VII
	-	A comparative pharmacodynamic study of anti-Xa activity to evaluate the accumulation effect of Tinzaparin and Enoxaparin given at prophylactic dose over 8 days in elderly patients with impaired renal function
	-	d-dimer levels: a prognostic value in patients with chronic atrial fibrillation
	-	Oral anti-coagulation in elderly patients in clinical practice: 187 patients
Causero A.	-	Efficacy of high purity, monoclonal factor IX concentrate for continuous infusion in an hemophilia B patient undergoing orthopedic surgery
Cauwenberghs S.	-	The platelet glycoprotein Ibalpha HPA-2 polymorphism affects VWF binding, but not thrombin interaction
Cavalheiro-Filho C.	-	Partial results of the incidence of Thrombocytopenia Induced Heparin
	-	Analysis of the effectiveness of the D-Dimer test to exclude acute venous thromboembolism
Cavalheiro-Fílho C.	-	Comparison of the point-of-care method for oral anti-coagulation control with the conventional method
Cavalieri G.	-	Management of oral anticoagulant therapy with Thrombotest® using a whole blood testing device (Thrombotrack®) in comparison to routine laboratory PT
	-	A comparison between routine plasma INRs and fingerstick whole blood INRs determinations, using three portable self-testing devices (Coagucheck®, Pro-Time®, Gem-PLC®) and a near-patient whole blood device (Thrombotrack®)
Cavo M.	-	Venous thromboembolic complications in patients with multiple myeloma treated with thalidomide:prophylatic effect of fixed dose Wafarin L
Cawston E.	-	Variation in antithrombin helix A impedes secretion and function of the inhibitor
Cazenave J-P.	-	The role of the P2Y1, P2Y12, and P2X1 platelet receptors in a laser-induced model of arterial thrombosis in vivo
Cazenave J.-P.	-	A key role of the fast ATP-gated P2 X 1 cation channel in the thrombosis of small arteries in vivo
	-	Evidence for a PLCg2-independent alpha2beta1-triggered signalling pathway contributing to platelet aggregation in response to collagen
	-	A key role of the fast ATP-gated P2X1 cation channel in the thrombosis of small arteries in vivo
Cazenave J-P.	-	PLC g-dependent GPIb signaling following platelet adhesion to von Willebrand factor through a pathway distinct from FcR g chain and FcgRIIA
Cecchi E.	-	Hyperhomocysteinemia as a risk factor for TIA and stroke in patients with AF
	-	Rate of adverse events during OAT in patients with mechanical prosthetic heart valves replacement
Cecil T.	-	Peri-operative bleeding in patients with Pseudomyxoma peritonei appears to relate to trauma induced hypofibrinogenemia
Cederholm I.	-	Studies of blood coagulation and platelet function in thoracic surgery utilizing a point of care instrument, a free oscillation rheometer
Cederlund K.	-	A comparison of spiral computed tomography and latex agglutination D-dimer assay in acute pulmonary embolism using pulmonary arteriography as Gold Standard
	-	Spiral computed tomography has a higher sensitivity and specificity than d-dimer in the diagnosis of acute pulmonary embolism
Ceelie H.	-	Identification of transcription factor binding sites for HNF1-alpha, FOXA2, HNF4-alpha, Sp1 and Sp3 in the human prothrombin gene enhancer
	-	Functional analysis of the prothrombin (PT) G20210A variation
Celardo A.	-	Injection of the inflammatory peptide fMLP in the rabbit induces transient myocardial ischemia: role of thromboxane A2
Celestini A.	-	Aggregometric evidence of a progressive reduction of platelet sensitivity to aspirin
Celestini A.	-	A polyphenol mixture inhibits collagen induced platelet aggregation
Celie P. H. N.	-	Factor VIII – factor IX interactions probed by chimeric factor VIII/V variants: complex assembly and cofactor function involve different residues within the A3 domain region 1803–1818
Celikel R.	-	Modulation of von Willebrand factor A1 domain binding to glycoprotein Iba by a-thrombin
Celikel R.	-	Crystal structure of the amino terminal domain of glycoprotein Iba in complex with a-thrombin
Celinska-Lowenhoff M.	-	Immediate anti-coagulant and anti-inflammatory effects of simvastatin and fenofibrate in patients with coronary artery disease
Celinska-Lowenhoff M.	-	Thrombin generation in response to methionine loading test in patients with ischemic heart disease
Cellai A. P.	-	Hemostatic changes in laparoscopic and laparotomic gynecological surgery
	-	Emerging prognostic factors in ischemic heart disease
	-	Effects of HRT with estradiolvalerate 2-mg + levonorgestrel 75 µg (NUVELLE®) on clotting and lipid profile
Celleno R.	-	Impairment of fibrynolytic capacity in experimentally induced ketoacidosis in continuous subcutaneous insulin infusion patients
Cellini C.	-	Venous thromboembolic complications in patients with multiple myeloma treated with thalidomide:prophylatic effect of fixed dose Wafarin L
Cen J.	-	Quantitative analysis of gene expression for vascular endothelial growth factor and its application
Cerasuolo L.	-	Transdermal hormone replacement therapy does not affect hemostasis and inflammation
Ceresa E.	-	Characterization of monoclonal antibodies that inhibit either the activation of proCPU (TAFI) or the activity of CPU (TAFIa)
Ceresetto J.	-	High levels of factors VIII, IX and XI in patients with a thromboembolic event
	-	Safety considerations of Enoxaparin as an alternative to oral anti-coagulants in high risk cardioembolic patients with a programed surgical procedure. SWITCH trial
Cerini C.	-	The uremic retention solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair in vitro
Cerletti C.	-	Beta-2 integrin adhesion triggered by E-selectin in human PMN: role of SRC kinases and of an unidentified receptor
	-	Pharmacological and cellular bases of some anti-thrombotic properties of extravirgin olive oil: studies on oleuropein and hydroxytyrosol
Cerletti C.	-	Are daily doses of 80 and 160 mg of aspirin bioequivalent? A pharmacokinetic and pharmacodynamic approach
Cerletti C.	-	Injection of the inflammatory peptide fMLP in the rabbit induces transient myocardial ischemia: role of thromboxane A2
	-	SRC-dependent signaling is a key step in the process of autoregulation of Mac-1 adhesive function in human PMN
	-	Effect of extra virgin olive oil on experimental thrombosis and primary haemostasis in rats
Cermak J.	-	Influence of oxidatively modified low-density lipoproteins on platelet function
Cernelc P.	-	Utility of in vitro closure time (PFA-100TM) for evaluating platelet related primary hemostasis in dialysis patients
Cerrato G.	-	Inherited and acquired prothrombotic risk factors in women with early or late pregnancy losses
Cerrutti C.	-	Identification and characterisation of MIP-1b and VE-Cadherin as important markers of acute rejection after human heart transplantation
Certad G.	-	Acquired platelet dysfunction with eosinophilia in children: A tropical disease present in Venezuela
Cesari F.	-	Protein Z levels in acute coronary syndromes
Cesnjevar R.	-	Application of human factor XIII in children with massive pleural effusions after open heart surgery
Cetin I.	-	Intruterine Growth Restriction (IUGR) and thrombophilic polymorphisms
Chabaud S.	-	Predictive factors of cancer discovery after deep-vein thrombosis: a 8-years follow-up study
Chabert C.	-	Effect of hyperhomocysteinemia on paraoxonase activity
Chabielska E.	-	Antithrombotic action of perindopril in experimental venous thrombosis in young rats
Chabielska E.	-	Thrombolytic effect of AT1 receptor antagonists – losartan and its metabolite EXP 3174 in rat
Chabielska E.	-	Effect of angiotensin II and their metabolites on hemostasis in rats
	-	Biological and pharmacokinetic activity of the new recombinant thrombolytic and anthithrombotic agent RGD SAK-K2-HIR
Chabrov A. M.	-	Changes in hemostatic system in oncogynecologic patients
Chabut D.	-	A new co-operative effect of low molecular weight polysaccharides and cell surface heparin sulfate in enhancing bFGF-induced endothelial cell differentiation
Chackalamannil S.	-	Antithrombotic effects of selective P2Y1 and P2Y12 antagonists in anesthetized rats
Chadha M.	-	Prevalence of anti-Erythropoietin antibodies in end stage renal disease patients treated with recombinant Erythropoietin
Chafa O.	-	Functional consequences of a factor VII gene donor splice site mutation causing a lethal factor VII deficiency: regulation in the splice site selection
Chagnon I.	-	Diagnosing pulmonary embolism with clinical assessment, d-dimer, venous ultrasound and helical computed tomography: a multicenter management study
Chai S. J.	-	Activated Recombinant Factor VII (rFVIIa) for the reversal of hepatic and warfarin induced coagulopathy prior to invasive procedures
Chait P.	-	Vena cava filters in children: review of a single centre clinical experience over 7 years
	-	Central venous catheter-related thrombosis presenting as SVC syndrome in a hemophiliac with inhibitors
	-	Central venous catheter (CVC) related thrombosis in boys with hemophilia
Chakroun T.	-	The role of tissue factor on the inhibition of prothrombin activation and thrombin generation by the synthetic pentasaccharide (fondaparinux)
Chakroun T.	-	Effect of Fondaparinux on clot formation after tissue factor pathway activation. A thromboelastography study
Chakroun T.	-	Effect of rFVIIa (NovSeven®) on thrombin generation in patients with severe thrombocytopenia
	-	The role of tissue factor on the inhibition of prothrombin activation and thrombin generation by the synthetic pentasaccharide (fondaparinux)
Chalabreysse L.	-	Identification and characterisation of MIP-1b and VE-Cadherin as important markers of acute rejection after human heart transplantation
Chalmers E. A.	-	Catheter-related venous thrombosis in children diagnosed by magnetic resonance venography
	-	Thromboembolism in childhood: a prospective 2 years study in the United Kingdom (February 2001 – February 2003)
Chambost H.	-	Efficacy and safety of the first nanofiltered plasma-derived FVIII (FACTANE®) in previously treated haemophilia A patients
Chammanthoon S.	-	Detection of the factor XIIIA Val34Leu polymorphism in Thais
Chamone D. A. F.	-	Comparison of the point-of-care method for oral anti-coagulation control with the conventional method
	-	Inherited prothrombotic risk factors in a Brazilian cohort with CVT
	-	Partial results of the incidence of Thrombocytopenia Induced Heparin
	-	Venous thromboembolism (VTE) in children: a series of cases from a pediatric Brazilian cohort
	-	Analysis of the effectiveness of the D-Dimer test to exclude acute venous thromboembolism
	-	Successful use of Arixtra® in a patient with PNH, Budd–Chiari syndrome and HIT
	-	Factor VII deficiency and stroke: case report
	-	Acquired prothrombotic-associated factors in cerebral venous thrombosis (CVT)
Chan A. K. C.	-	A case series of 72 neonates with renal vein thrombosis: data from 1 to 800-No-Clots registry
Chan A.	-	Ex vivo thrombin generation capacity in pediatric patients receiving Tinzaparin
Chan A. K. C.	-	A dose-finding study of Tinzaparin in pediatric patients
Chan A. K.	-	Predictors of recurrent thrombo-embolic events in 153 infants and children with cerebral sinovenous thrombosis: a national population based study
Chan K-W	-	Molecular basis of the bleeding disorder caused by Prothrombin-Vancouver
Chan A. K. C.	-	Binding of heparin to alkaline earth and transition metals
	-	Isoform composition of antithrombin (a-AT vs. b-AT) in a covalent antithrombin-heparin complex
Chan L.	-	Safety of low intensity warfarin regimen in Chinese patients With mechanical heart valve prostheses
Chan A. K. C.	-	The effect of age on plasmin generation in the presence of fibrin monomer on endothelium
	-	A pharmacokinetic study of tinzaparin in pediatric patients
	-	Use of low molecular weight heparin in children with thromboembolic events; predictors for bleeding and recurrence on therapy
	-	Binding of covalent antithrombin–heparin complex to endothelial cells
Chan A. K.	-	Reversal of warfarin or low molecular weight heparin (LMWH) using subcutaneous unfractionated heparin (UFH) in pediatric outpatients with an ongoing high risk for thrombosis and requiring invasive procedures: a prospective cohort study of 146 children
	-	Vena cava filters in children: review of a single centre clinical experience over 7 years
Chan A. K. C.	-	Activated protein C generation is greatly decreased in plasma from newborns compared to adults in the presence or absence of endothelium
	-	Effect of protein binding on the anti-FXa activity of different heparinoids in either adult or newborn plasma
Chan A. K.	-	Venous thrombosis in children
Chan A. K. C.	-	Effect of heparin on thrombin generation in factor VIII depleted plasma supplemented with FEIBA or FVIII
Chan A. K.	-	Very low dose warfarin for primary and secondary prophylaxis in children: a prospective cohort study of 20 children
	-	Reversal of low molecular weight heparin (LMWH) prior to invasive procedures using subcutaneous unfractionated heparin in children with an ongoing high risk for thrombosis
	-	Low molecular weight heparin therapy in neonatal cerebral sinovenous thrombosis: a consecutive cohort study
Chance D.	-	A new method for identification of false-negative testing for lupus anticoagulant due to contamination of test plasma by platelet-derived micropatricles
Chandan K.	-	Elevated factor VIII: a possible link between periodontal disease and acute coronary syndrome
Chandler W. L.	-	Active thrombin concentrations and the rate of thrombin inhibition during cardiopulmonary bypass
Chandler R.	-	Hemophilia A: total correction in mice and partial correction in dogs with canine FVIII using a new AAV serotype
Chandra D.	-	Prophylactic factor replacement therapy in children with severe factor X deficiency
Chandramouli B.	-	The three I hemophilic study: a comparative study of the morbidity pattern between Asian Indian, Iranian and Italian PWH
Chandy M.	-	Factor IX gene deletions are a frequent cause of hemophilia B in India
	-	Administration of gentamicin does not increase factor levels in severe hemophilia-B due to premature termination codons
	-	Three novel missense mutations in the b-propeller domains of GPIIb (aIIb integrin) among three unrelated patients with Glanzmann thrombasthenia from southern India
Chang K. M.	-	Critical lower limb ischemia caused by essential thrombocytosis and successful limb salvage using angiographic-guided intra-arterial thrombolysis with rTPA
Chang Y. J.	-	Enhanced anti-angiogenesis ability of human kringle 1–5 domain via altering glycosylation sites and lysine binding properties
Chang C. W.	-	Enhanced anti-angiogenesis ability of human kringle 1–5 domain via altering glycosylation sites and lysine binding properties
Channell C.	-	Phospholipid-dependent impairment of the inhibitory properties of hirudin: the cause of false-positive assays for lupus anticoagulants (LAs)
Channon K. M.	-	Platelet activation and platelet VASP phosphorylation in mice with streptozotocin-induced diabetes mellitus – association with endothelial dysfunction and reduced nitric oxide bioactivity
Chantarangkul V.	-	Thrombin generation assessed as endogenous thrombin potential (ETP) in patients with hyper- or hypo-coagulability. Effects of phospholipids, tissue factor and residual platelets on the measurement performed in platelet-poor and platelet-rich plasma
	-	Standardization of activated protein C resistance testing: effect of residual platelets in frozen plasmas assessed with commercial and home made methods
Chaos N.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Charles L.A.†	-	The effect of drotrecogin alfa (Xigris) on the biphasic PTT waveform in patients with sepsis
Charles L. A.	-	Biphasic PTT waveform and adverse events in nonintensive care unit patients
Charvier S.	-	Deficiency in one Gas6 receptor (Axl, Sky or Mer) protects mice against thrombosis because of a platelet dysfunction
Chasapopoulou H.	-	Thrombophilia and pregnancy
Chassé J. F.	-	Effect of hyperhomocysteinemia on paraoxonase activity
Chauansumrit A.	-	Heterogeneous molecular pattern of Factor VII deficiency associated to cerebral hemorrhage
Chaubey S.	-	A patient with factor V Leiden who rapidly developed fatal heparin induced thrombocytopenia
Chauhan N.	-	European concerted action on anti-coagulation (ECAA). Correction of displayed INR on two point-of-care test (POCT) whole blood prothrombin time monitors (CoaguChek Mini and TAS PT-NC) by independent International Sensitivity Index (ISI) calibration
	-	European concerted action on anti-coagulation (ECAA). reliability of International Normalized Ratios (INR) from CoaguChek mini and TAS PT-NC whole blood point-of-care test monitor systems
Chauleur C.	-	Venous thromboembolism during pregnancy and postpartum: results from a prospective cohort of women treated according to a risk score
Chavakis T.	-	Regulation of neovascularization by a-defensins: a link between inflammation and angiogenesis
Chavakis T.	-	Human antibody against CD11b inhibits platelet–leukocyte interaction under high shear
Cheang K. I.	-	Polymorphisms in the 5'UTR of the tissue factor (TF) gene are associated with differences in total and surface clotting activity and TF mRNA of endothelial cells
Checcucci V.	-	Effects of HRT with estradiolvalerate 2-mg + levonorgestrel 75 µg (NUVELLE®) on clotting and lipid profile
Chediak J.	-	Temporal patterns and clinical outcomes in patients with heparin – induced thrombocytopenia
Chee Y.	-	Routine coagulation screening to predict surgical bleeding is frequently misleading, of no significant clinical value and should be abandoned: results of a systematic review
Chee Y. L.	-	Thrombolytic properties of normal human neutrophils
Chee Y-L.	-	Plasminogen activators: a feature of normal myeloid differentiation or leukemic transformation?
Chen D.	-	Targeted expression of tissue factor pathway inhibitor and hirudin fusion proteins to endothelial cells reduces pathology in murine LPS-induced endotoxic shock – a novel model to study vascular inflammation
Chen C.-S.	-	PIP3 induces human platelet aggregation via an activation of a nonselective cation entry channel
Chen Y. X.	-	Immunohistochemical expression of interleukin-10 (IL-10) in atherosclerotic intimas of human coronary arteries
Chen D.	-	Expression of human tissue factor pathway inhibitor and hirudin fusion proteins on mouse vascular smooth muscle cells inhibits vascular remodeling after wire-induced carotid artery injury
Chen W.	-	A prospective randomized trial of anti-platelet therapies in patients with carotid artery disease (preliminary results)
Chen P.	-	Autoantibodies to recombinant PSI domain but not to cytoplasmic tail of beta3 integrin cause immune thrombocytopenia
Chen Z.	-	Quantitative analysis of gene expression for vascular endothelial growth factor and its application
Cheng X.	-	Soluble platelet GPV: a new marker of thrombosis status
Cheng S.	-	Identification of two novel point mutations in XIII A chain gene associated with congenital deficiency in a Chinese FXIII deficiency family
Cheng T.	-	Activated protein C (APC) blocks p53-mediated apoptosis in ischemic human brain endothelium through endothelial protein C receptor (EPCR) and protease activated receptor 1 (PAR-1)
	-	In vivo activated protein C (APC) neuroprotective activity involves endothelial protein C receptor (EPCR) and protease activated receptor 1 (PAR-1)
Chenou C.	-	Comparability study of two purification processes of a plasma-derived anti-thrombin
Cheong J.	-	Pharmacokinetics of recombinant human FXIII in cynomolgus monkeys
Cherel G.	-	The substitution of the factor Xa a-helix 345–352, which is a factor Va interactive site, by the corresponding structure of factor IXa does not affect formation and activity of the prothrombinase complex
	-	Role of the Gla and first EGF-like domains of Factor X in the Prothrombinase and Tissue Factor-Factor VIIa complexes
Chereshnev I.	-	P-Selectin deficiency results in impaired thrombus formation and frequent embolization in mouse model of carotid artery thrombosis
Cherkasova K.	-	Protection of thrombosis by glyproline peptide Semax
Cherpi-Antar C.	-	Transcriptional silencing of TFPI-2 gene by hypermethylation of the promoter in choriocarcinoma cells
Cherubin E.	-	Incidence of recurrent ischemic stroke in children with coagulation abnormalities
Chesterman C.	-	The control of von Willebrand Factor multimer size by thrombospondin-1
Chevallier C.	-	Hypercoagulability in sickle cell disease: increased monocyte tissue factor expression and increased erythrocyte microparticles expressing phosphatidyl serine
Chew A.	-	A phase I/II trial of AAV-mediated, liver-directed gene transfer for hemophilia B
Chew H.	-	Incidental pulmonary embolism in patients with cancer
Chew E. M. D.	-	Radioisotopic synovectomy and haemophilic arthropathy in Asians: a retrospective study
Chi H. S.	-	Polymorphisms of 5,10-methylenetetrahydrofolate reductase gene and risk of Korean acute leukemia
Chi L.	-	Compound 48/80 inhibits thrombosis in balloon-injured arteries of hypercholesterolemic rabbits by inhibiting TF/FVIIa-mediated coagulation
Chiang T.	-	Clinical profile of rare coagulation disorders in an Asian population
Chiarenza A.	-	Sickle cell disease, vascular endothelium dysfunction, abnormal endothelin-1 release, interleukin-6 plasma level, hyperhomocysteinaemia and thromboembolic risk
Chiarion C.	-	Management of hospitalized patients with suspected deep vein thrombosis
Chiles P. G.	-	A novel method of measuring fibrinopeptide B for the detection of venous thromboembolism
Chilver-Stainer L.	-	Titer of anti-heparin/PF4-antibodies and extent of in vivo activation of the coagulation and fibrinolytic systems
Chimini G.	-	The role of the ATP-Binding Cassette transporter A1 (ABCA1) in phosphatidylserine cell surface exposure and in the modulation of the procoagulant phenotype
Chin K. W.	-	Projection parameters for usage of blood products in Singapore General Hospital
Chin B.	-	Increased plasma tissue factor predicts adverse outcome in chronic heart failure
Chindemi P.	-	Binding of covalent antithrombin–heparin complex to endothelial cells
CHINESE CO-OP ANTICOAGULATION‡	-	Safety of low intensity warfarin regimen in Chinese patients With mechanical heart valve prostheses
Chini J.	-	Cytokine gene expression and production in human LPS-stimulated mononuclear cells are inhibited by sulfated heparin-like semi-synthetic derivatives
Chintala M.	-	Antithrombotic effects of selective P2Y1 and P2Y12 antagonists in anesthetized rats
Chirivella M.	-	Quantitative real-time reverse transcription-PCR (RT-PCR) assay for urokinase plasminogen activator, plasminogen activator inhibitor type 1 and tissue metalloproteinase inhibitor type 1 gene expression and protein levels in endometriosis
Chisolm G. M.	-	Lysophosphatidylcholine induction of chemokines in human microvascular endothelial cells is dependent on the activation of MAP kinases and PI3 kinase
Chitayat S.	-	A ligand-induced conformational change in apolipoprotein(a) enhances covalent Lp(a) assembly
Chitolie A.	-	Direct association of HCII and red blood cells
Cho H. C.	-	Thrombin-activatable fibrinolysis inhibitor is not associated with the occurrence of ischemic stroke
Cho M. J.	-	The peptide LSARLAF directly induces a conformation change in the platelet integrin aIIbb3
Cho L.	-	Issues in monitoring direct thrombin inhibitors: comparison of a new, rapid Ecarin Clotting Time (ECT) test to activated clotting time (ACT) and anti-IIa assays
Cho M.	-	The anti-platelet activity of J78 is mediated mainly by inhibition of arachidonic acid metabolism
Cho E. Y.	-	Polymorphisms of 5,10-methylenetetrahydrofolate reductase gene and risk of Korean acute leukemia
Choi E. J.	-	Hereditary coagulation factor deficiencies in Korea
Choi J. R.	-	Detection of Ala601-Thr mutation in dysplasminogenemic patients with thrombosis in Korean population
Choi S. E.	-	A collaborative study to establish a Korean standard for factor VIII : C concentrate
	-	A collaborative study to establish a Korea National Biological Standard for antithrombin III concentrate
Choi O. H.	-	Characterization of mutations of the factor VIII gene in Korean hemophilia A patients
Chollet-Martin S.	-	Fractalkine/CX3CL1 production by human aortic smooth muscle cells impairs monocyte procoagulant and inflammatory responses
Chong B. H.	-	Qualitative Bernard Soulier syndrome: characterization of a normally expressed but functionally abnormal GPIb alpha
Chong A.	-	Endothelial damage in congestive heart failure (CHF): relationship between circulating endothelial cells (CECs) and von Willebrand factor (vWf)
Chong B. H.	-	Protein–protein interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocyte-specific genes through cooperative DNA-binding
Chong A. Y.	-	Which is the ideal plasma marker of endothelial damage/dysfunction in atrial fibrillation? A comparison of von Willebrand factor, E-selectin and soluble thrombomodulin
Chong B.	-	Heparin induced thrombocytopenia
Chong C.	-	A multinational observational cohort study in hospitalized medical patients of practices in prevention of venous thromboembolism and clinical outcomes: findings of the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)
Choolani M.	-	Plasminogen activators, plasminogen activator inhibitor-1 and D-dimer levels in gynecological cancer
Choporev L.	-	Changes in hemostatic system in oncogynecologic patients
Chorin S.	-	Thrombophilic risk factors and idiopathic sudden sensorineural hearing loss
Chotsupakarn S.	-	Cost-effectiveness in establishing carrier detection and prenatal diagnosis services in a developing country with limited health resources
Choudhary S.	-	Alterations in intraplatelet Ca2+ mobilization by functional antiheparin-PF4 antibodies: Implications in the signaling mechanisms during HIT pathogenesis
	-	Prevalence of anti-Erythropoietin antibodies in end stage renal disease patients treated with recombinant Erythropoietin
Chow B.	-	Correlation of the serum ferritin (SF) levels with cholesterol and body mass index (BMI) in patients with advanced atherosclerosis
Chow B. K.	-	Reducing body iron stores lowers inflammatory cytokine levels in atherosclerotic claudicants
Chowdhury P.	-	The efficacy of standard dose vs. 30 mL kg-1 FFP in correcting laboratory parameters of hemostasis in critically ill patients
Chretien M.-H.	-	Protein C promoter polymorphisms are potential additional risk factors for cerebral venous thrombosis
Christ G.	-	The effect of b-receptor blockade on factor VIII levels and thrombin generation in patients with venous thromboembolism
	-	The effect of pretreatment with clopidogrel on platelet and coagulation activation in patients with stable angina undergoing elective coronary stenting
Christaras A.	-	Severe intracranial hemorrhage in a patient with von Willebrand disease type 2B after being hit by a golf ball
Christiaens L.	-	Recurrent thrombosis in a young patient with a left-sided inferior vena cava and factor V Leiden and prothrombin 20210A
Christian K.	-	Purification and formulation of a dual viral-inactivated fibrinogen concentrate for use in a fibrin sealant
Christianansen K.	-	Mutation analysis in type 1 von Willebrand disease patients entered in the multicenter MCMDM-1VWD study
Christiansen K.	-	Sample management and quality control in roTEG thrombelastography
Christiansen S.	-	Risk factors for recurrent venous thrombosis: a prospective follow-up of the Leiden thrombophilia study (LETS)
Christiansen K.	-	Development of inhibitors against factor VII in patient with severe factor VII deficiency
	-	Whole blood coagulation profiles in patients with thrombosis
	-	Hyperhomocysteinemia (HH) down regulates thrombin generation. FII:C, FXII:C and FX:C are down-regulated in HH while FVII:C is unaffected by HH
Christiansen V. J.	-	A novel plasma proteinase that enhances incorporation of a2-antiplasmin into fibrin
Christophe O. D.	-	The substitution of the factor Xa a-helix 345–352, which is a factor Va interactive site, by the corresponding structure of factor IXa does not affect formation and activity of the prothrombinase complex
	-	Role of the Gla and first EGF-like domains of Factor X in the Prothrombinase and Tissue Factor-Factor VIIa complexes
Christy J. R. E.	-	An in vitro model for assessing the thrombogenic potential of mechanical prosthetic heart valves
	-	A microscopic evaluation of the influence of fluid dynamics on the clotting of a blood analog fluid
Chtourou S.	-	Comparability study of two purification processes of a plasma-derived anti-thrombin
Chua S. E.	-	Plasminogen activators, plasminogen activator inhibitor-1 and D-dimer levels in gynecological cancer
Chua M. L.	-	Projection parameters for usage of blood products in Singapore General Hospital
Chua S. E.	-	Coagulation and fibrinolysis during the menstrual cycle and the effects of increased body mass index
Chuah M.	-	Gene therapy for hemophilia A with high-capacity adenoviral vectors: preclinical evaluation in hemophilic mice and dogs
Chuah M. K. L.	-	Gene therapy for haemophilias
Chuang Y.-J.	-	Quantitative transcript profiling and novel gene identification of vascular endothelial cell subtypes by serial analysis of gene expression (SAGE)
Chuansumrit A.	-	Cost-effectiveness in establishing carrier detection and prenatal diagnosis services in a developing country with limited health resources
Chuansumrit A.	-	Successful use of recombinant activated factor VII for controlling bleeding in patients receiving invasive surgeries
	-	The use of recombinant activated factor VII for controlling life-threatening bleeding in dengue shock syndrome
Chuansumrit A.	-	Prevalence of Arg 506 and Arg 306 mutations of the factor V gene in Thai blood donors
Chudzinski-Tavassi A. M.	-	Platelet responses mediated by venom snake metalloproteases (MP1 and MP3)
Chudzinski-Tavassi A. M.	-	Recombinant Lopap (a prothrombin activator from Lonomia obliqua) has a very conservative structure of lipocalins
Chung K. H.	-	A novel plasma proteinase that enhances incorporation of a2-antiplasmin into fibrin
Chung K. C.	-	Economic evaluation of anti-D immunoglobulin in the treatment of immune thrombocytopenic purpura in adults in the United Kingdom
Chung C. H.	-	Aggretin, a snake venom-derived endothelial integrin a 2b 1 agonist, induces angiogenesis in vitro and in vivo via expression of vascular endothelial growth factor
Chung N.	-	Increased plasma tissue factor predicts adverse outcome in chronic heart failure
Chung H. J.	-	A common variant in the methylenetetrahydrofolate reductase (MTHFR) gene and its association with a haplotype in the Korean population
Church F. C.	-	Role of surface amino acid residues in thrombin essential for inhibition by antithrombin, heparin cofactor II and protein C inhibitor
	-	Effect of a RNA-thrombin aptamer on thrombin inhibition by antithrombin, heparin cofactor II and protein C inhibitor
	-	Plasminogen activator inhibitor-1 (PAI-1) confers a survival advantage to breast cancer cells
Chwatko G.	-	Is plasma homocysteine concentration different in diabetic and nondiabetic stroke patient up to the age of 55?
Chybicka A.	-	Recombinant activated coagulation factor VII for the treatment of spontaneous bleeding in a girl with inhibitors developed after autologus bone marrow transplantation
Ciampa A.	-	The strong incidence of acquired and inherited thrombophilia in recurrent first trimester fetal loss
Ciampa A.	-	Thrombosis do not recur at conventional dose oral anticoagulation (INR 2–3) in primary anti-phospholipid syndrome: comparison with inherited thrombophilia at similar INR
	-	Women with common prothrombotic mutations are not at higher risk of recurrent intrauterine fetal deaths
Ciaravino V.	-	Preclinical safety assessment of photochemically treated platelets: no toxicologically relevant effects with large multiples of the clinical exposure
Ciccarone E.	-	NAD(P)H oxidase C242T gene variations and cardiovascular protection
	-	Hyperhomocysteinemia is associated with the progression of peripheral arterial disease in type 2 diabetic patients
Cicinelli E.	-	Short-term effects of raloxifene on the main anti-coagulant systems in postmenopausal women
Cid A. R.	-	Treatment with recombinant activated factor VII of intra-abdominal bleeding associated with disseminated intravascular coagulation caused by septic shock
Cid A. R.	-	Detection the 3614 G > A (R1205H) mutation in the VWF gene in 26 Spanish patients with high penetrance dominant type 1 von Willebrand disease
Cierniewska-Cieslak A.	-	Up-regulation of plasminogen activator inhibitor-1 (PAI-1) by thymosinb 4 in endothelial cells
Cierniewski C. S.	-	Up-regulation of plasminogen activator inhibitor-1 (PAI-1) by thymosinb 4 in endothelial cells
	-	The role of vascular endothelial growth factor in an early phases of proangiogenic changes in human endothelial cells
	-	The role of integrin alpha2beta1 during activation of protein tyrosine kinases induced by low concentration of collagen
	-	Down-regulation of PAI-1 expression by natriuretic peptides is mediated by MAPK cascade in human endothelial cells
Cimino M.	-	Post-treatment of rats with simvastatin affords brain protection after focal ischemia as assessed by magnetic resonance imaging
Cimino G.	-	Preclinical safety assessment of photochemically treated platelets: no toxicologically relevant effects with large multiples of the clinical exposure
Cimminiello C.	-	Prevalence and impact on clinical outcome of concomitant peripheral arterial disease (PAD) in patients with coronary and cerebrovascular diseases: the Pathos project
Cines D. B.	-	A novel platelet-specific delivery system for fibrinolytic agents
	-	Mapping the interaction between uPAR and high molecular weight kininogen
	-	Transgenic mice studies demonstrate a role for platelet factor 4 (PF4) in thrombosis: implications for heparin-induced thrombocytopenia (HIT)
	-	Regulation of neovascularization by a-defensins: a link between inflammation and angiogenesis
	-	PF4 and heparin form high molecular weight complexes that is central to the pathogenesis of Heparin-Induced Thrombocytopenia
Cini M.	-	Thrombophilia and residual vein thrombosis are independent risk factors for recurrent venous thromboembolism
	-	D-dimer and residual vein thrombosis assessed at 3 months after anti-coagulation withdrawal are independent risk factors for recurrent venous thromboembolism
	-	Risk of recurrence of venous thromboembolism (VTE) and high factor VIII plasma levels
	-	The risk of recurrence after a first episode of venous thromboembolism in cancer patients
	-	Venous thromboembolic complications in patients with multiple myeloma treated with thalidomide:prophylatic effect of fixed dose Wafarin L
	-	Markers of inflammation, d-dimer and recurrences after a first episode of venous thromboembolism
Cinotti R.	-	Clinical quality assessment program for the oral anti-coagulant clinic: preliminary report of a multicentric Italian exercise
Ciocoiu M.	-	Platelet adhesion index and soluble E-selectin in the prediction of cardiovascular risk
Ciocoiu M.	-	Platelet-mediated vasodilatation factor activated by Zinc on diabetic rats
Cirera I.	-	Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vitro model
Cironi J.	-	‘Video Grand Rounds’: an assessment of internet based grand rounds to increase collaboration between comprehensive hemophilia treatment centers
Cisneros J. M.	-	Natural history of hepatitis C infection in hemophilia patients at Hospital Universitario Virgen del Rocío (Sevilla, Spain)
	-	Interferon and ribavirin in patients with chronic hepatitis C and congenital bleeding disorders
Citak A.	-	A single dose (0.8 g kg) of intravenous immunoglobulin in children with acute immune thrombocytopenic purpura
Cittadini E.	-	Prevalence of haemostatic abnormalities in women with 3 or more implantation failures after in vitro fertilization
Claes N.	-	The quality of care in the management of oral anti-coagulation therapy by the Belgian general practitioner
Clark P.	-	Thrombophilia in pregnancy, combined oral contraceptives and hormone replacement therapy users: a systematic review
Clark D.	-	Underlying platelet function disorders and von Willebrand disease in children with epistaxis or menorrhagia
Clark P.	-	The effect of ABO and Secretor genotypes on thrombin generation
Clark P.	-	The risk of thromboembolism and the effectiveness of prophylactic treatment in thrombophilia patients undergoing major orthopaedic surgery: a systematic review
	-	Screening for thrombophilia: an economic assessment
Clark D.	-	Stability of dilutions of the recombinant factor VIII Kogenate FS stored in syringes
Clark P.	-	The G>T point mutation in codon 34 of the factor XIII gene and the risk of pre-eclampsia
	-	Anticardiolipin antibodies and pregnancy outcome: a prospective study in an unselected obstetric population
Clarke R.	-	Homocysteine as a risk factor for cardiovascular disease and venous thrombosis
Clarke B. J.	-	Fibrinolysis within the procoagulant VX-2 tumor of rabbit lungs in vivo: Anti-angiogenic behavior of fibrin(ogen) degradation products
Clarke C.	-	A humanized monoclonal antibody against vWF A1 domain inhibits vWF:RiCof activity and platelet adhesion in human volunteers
Clarke B.	-	Interspecies exchange mutagenesis of the first epidermal growth factor-like domain of human factor VII
Clasby M.	-	Antithrombotic effects of selective P2Y1 and P2Y12 antagonists in anesthetized rats
Clauser K.	-	CD84 signaling is a novel platelet stimulatory mechanism that occurs during platelet aggregation
Clavies M. C.	-	Two sensitive chromogenic assays of fondaparinux sodium (Arixtra®), a new synthetic and selective inhibitor of factor Xa, in plasma
Clayssens S.	-	Safety and efficacy of Fibrogammin P® for the treatment of patients with severe FXIII deficiency
Cleator J. H.	-	Differences in protease activated receptor-1 stimulation between vWF and P-selectin release in endothelial cells-implications of distinct signaling of Weibel–Palade release
Clement A. M.	-	The bedside investigation of pulmonary embolism diagnosis (BIOPED) study- a triple blind randomized control trial comparing initial bedside diagnostic tests to standard care (initial V/Q scan) in the investigation of patients with suspected PE
Clemetson J. M.	-	Labrirhagin, a protein with metalloprotease and disintegrin domains from Trimeresurus albolabris venom, activates platelets by a mechanism involving GPVI, aIIbbIII3
Clemetson K. J.	-	Labrirhagin, a protein with metalloprotease and disintegrin domains from Trimeresurus albolabris venom, activates platelets by a mechanism involving GPVI, aIIbbIII3
Clemetson K.	-	New antiplatelet agents
Clemetson K. J.	-	Crystal structure at 1.7 A of aggretin, a heterodimeric C-type lectin snake venom protein
	-	Cross-linking of GPIb by echicetin/biotinylated-IgMk/avidin induces strong GPIIb/IIIa activation and platelet aggregation
	-	Glycoprotein IX Asn45Ser: an ancestral mutation causing Bernard–Soulier syndrome in Europeans?
	-	Platelet activation causes a metalloprotease-mediated down-regulation of GlycoproteinVI
Clemetson J.	-	Structure of the Glycoprotein Ib N-terminal domain
Clemetson K.	-	Structure of the Glycoprotein Ib N-terminal domain
Clemmitt R.	-	Purification and formulation of a dual viral-inactivated fibrinogen concentrate for use in a fibrin sealant
Clerici M.	-	Thrombin generation assessed as endogenous thrombin potential (ETP) in patients with hyper- or hypo-coagulability. Effects of phospholipids, tissue factor and residual platelets on the measurement performed in platelet-poor and platelet-rich plasma
Clerin V.	-	Role of platelet-leukocyte–endothelium interactions in neointimal hyperplasia
CLETRAT INVESTIGATORS¶	-	Efficacy and safety of once-daily Enoxaparin given in the outpatient setting compared with in-hospital unfractionated heparin for treatment of proximal lower limb deep-vein thrombosis
Clijsters K.	-	Establishing links between coagulation and inflammation: The lectin-like domain of thrombomodulin confers protection in a murine model of rheumatoid arthritis
Climent V.	-	Hemostatic markers in nonrheumatic atrial fibrillation patients without anticoagulant therapy
Clutterbuck R.	-	High affinity heparin binding proteins are exposed on the surface and microvesicles of TF bearing cells and diminish heparin-mediated anticoagulation
	-	Heparin neutralising agents instigate the binding of heparin to live cells
Clyne C. D.	-	The cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia
Coca M.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Coccheri S.	-	D-dimer and residual vein thrombosis assessed at 3 months after anti-coagulation withdrawal are independent risk factors for recurrent venous thromboembolism
	-	Thrombophilia and residual vein thrombosis are independent risk factors for recurrent venous thromboembolism
	-	Risk of recurrence of venous thromboembolism (VTE) and high factor VIII plasma levels
	-	Markers of inflammation, d-dimer and recurrences after a first episode of venous thromboembolism
	-	The risk of recurrence after a first episode of venous thromboembolism in cancer patients
Coccia M. E.	-	Hemostatic changes in laparoscopic and laparotomic gynecological surgery
Cockerill P. N.	-	Human endothelial cell protein C receptor (EPCR) expression: role of proximal and distal 5'-gene regulatory elements
Cocomazzi N.	-	Women with common prothrombotic mutations are not at higher risk of recurrent intrauterine fetal deaths
Coen D.	-	Comparative evaluation of four rapid quantitative D-dimer assays
Coen D.	-	The combination of lupus anticoagulant sensitive and insensitive aPTT reagent together with dRVVT screening reagent for the exclusion of the presence of lupus anticoagulant
Cogo A.	-	Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism
Cohen A. T.	-	Prolonged prophylaxis against VTE with enoxaparin in patients undergoing surgery for malignancy: 1-year survival study
Cohen M.	-	Foundations of clinical practice - Arterial thromboembolism
Cohen A. T.	-	Thromboprophylaxis in medical patients: national survey of consultant physicians in the United Kingdom
Cohen A. T.	-	Fondaparinux vs. placebo for the prevention of venous thromboembolism in acutely ill medical patients (artemis)
Cohen H.	-	A proposed ISTH revised classification for the anti-phospholipid syndrome
Cohen A.	-	A randomized double-blind study to compare the efficacy and safety of fondaparinux with dalteparin in the prevention of venous thromboembolism after high-risk abdominal surgery: the Pegasus study
Cohen H.	-	Reduction in stillbirth and IUGR with aspirin +/- low molecular weight heparin treatment in pregnancy
Cohen A. T.	-	A randomized placebo controlled trial of dalteparin for the prevention of venous thromboembolism in 3706 acutely Ill medical patients: the PREVENT medical thromboprophylaxis study
Cohen H.	-	Venous thromboembolism and the -455G/Ab-fibrinogen gene polymorphism
Cohen A.	-	A risk assessment model for identifying medical patients who should receive thromboprophylaxis
Cohen A.	-	Extending standards of care to medical patient
Cohen A. T.	-	Fatal pulmonary embolism in medical patients
Cohen H.	-	Paradoxical association between the 316 Trp to Ser beta 2-glycoprotein I (beta2GPI) polymorphism and antibeta2GPI antibodies
Cohen H. W.	-	Is aspirin resistance more common in Black patients?
Cohen A.	-	Prophylaxis in medical patients
Cohen A. F.	-	A novel method to accurately measure collagen/serotonin-induced platelet aggregation by whole blood impedance aggregometry in humans
Cohen A. T.	-	Efficacy and safety of the treatment regimen of melagatran and ximelagatran for prevention of thromboembolic events after total hip or knee replacement: a meta-analysis of 3 randomized, double-blind studies, to evaluate the influence of time and dose
Cohen H. C.	-	Venous thromboembolism (VTE) associated with the management of acute thrombotic thrombocytopenic purpura (TTP)
Cohen M.	-	A novel recombinant tissue factor assay for measuring the anti-Xa effect of Low-Molecular-Weight Heparin (LMWH): implications for interventional coronary procedures
Cohen-Landau M.	-	Substitutions of conserved Gly193 (numbering according to chymotrypsin) located near the catalytic triad of factors VII, IX and XI yield dysfunctional proteins probably due to interference with accessibility of the respective substrates
Coignard B.	-	Pulmonary embolism in liver transplant setting associated with the use of solvent detergent plasma
Cokkinou V.	-	C-reactive protein: a link between inflammation and thrombosis formation in patients with unstable angina?
Colaizzo D.	-	Endothelial nitric oxide synthase gene variation and hypertension in pregnancy
Colaizzo D.	-	Prevalence of haemostatic abnormalities in women with 3 or more implantation failures after in vitro fertilization
	-	Occurrence of myocardial infarction and PAI-1 4G/5G and ACE I/D gene polymorphisms in patients on chronic dialysis
	-	Women with common prothrombotic mutations are not at higher risk of recurrent intrauterine fetal deaths
Colangello L. M.	-	Effects of isolated and combined use of ticlopidine, clopidogrel and aspirin on platelet function as evaluated by platelet aggregometry
Cole S.	-	A genome-wide scan for genetic loci influencing levels of thrombin-activatable fibrinolysis inhibitor (TAFI)
Colella A.	-	Angiotensin converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation
Coleman L.	-	Hypochlorous acid-oxidized LDL rapidly induces platelet aggregation in the presence of low levels of ADP, thrombin, epinephrine and chemokines
Colev-Luca V.	-	Platelet adhesion index and soluble E-selectin in the prediction of cardiovascular risk
Colina I.	-	Circulating prostaglandin E2 is associated with high risk of coronary heart disease in asymptomatic subjects: a novel inflammatory marker of subclinical atherosclerosis
Coll I.	-	The 46C®T polymorphism in the F12 gene is a risk factor for ischemic stroke
	-	Complexity of the genetic contribution to Factor VII deficiency in two Spanish families: clinical and biological implications
Collard C.	-	The clinical relevance of anti-b2-GP1 antibodies assays in the presence of antiphospholipid antibodies and/or lupus anticoagulant
Collen D.	-	Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice
	-	Gene therapy for hemophilia A with high-capacity adenoviral vectors: preclinical evaluation in hemophilic mice and dogs
	-	Establishing links between coagulation and inflammation: The lectin-like domain of thrombomodulin confers protection in a murine model of rheumatoid arthritis
	-	Endothelial-specific inactivation of survivin in mice results in embryonic lethality with intraembryonic bleeding due to loss of vascular endothelial integrity
	-	Gene therapy for haemophilias
	-	Deficiency in one Gas6 receptor (Axl, Sky or Mer) protects mice against thrombosis because of a platelet dysfunction
Coller B. S.	-	Biochemical, immunologic and computer-modeling evidence localizing the mAb 7E3 Epitope on aIIbb3
	-	P-Selectin deficiency results in impaired thrombus formation and frequent embolization in mouse model of carotid artery thrombosis
	-	A monoclonal antibody to the fibrinogen g chain alters clot structure and properties by producing thinner fibrin fibers arranged in bundles
	-	The molecular basis of Glanzmann thrombasthenia in Arabs
Colli S.	-	Reactive oxygen species mediate cyclooxygenase-2 induction during monocyte transition into macrophages: critical role for NADPH oxidase
Colliec-Jouault S.	-	A new co-operative effect of low molecular weight polysaccharides and cell surface heparin sulfate in enhancing bFGF-induced endothelial cell differentiation
Collins P.	-	Perspectives on the role of rAHF-PFM in clinical practice
Collins P.	-	The efficacy of standard dose vs. 30 mL kg-1 FFP in correcting laboratory parameters of hemostasis in critically ill patients
	-	Population-based study of acquired hemophilia A
Collins P.	-	Continuing clinical evaluation of an advanced category recombinant FVIII, antihemophilic factor (recombinant) plasma/albumin-free method (rAHF-PFM) in previously treated patients (PTPs)
Collins R.	-	Antiplatelet agents and statins in secondary prevention: which patients and which agents
Colman R. W.	-	A single point mutation of asparagine 511 to serine is responsible for the increased rate of cleavage of high molecular weight in Lewis rat, which is genetically susceptible to inflammatory stimuli
	-	Domain 5 (D5) of high molecular weight kininogen (HK) induces aggregation of human platelets
	-	Apoptotic effect of cleaved high molecular weight kininogen is selectively regulated by extracellular matrix proteins
	-	Thrombin activates the cGMP-inhibited cAMP-dependent phosphodiesterase (PDE3A) in platelets
Colombo M.	-	Polymorphisms of the interleukin 1-b gene, inflammatory and hemostatic response and the risk of premature myocardial infarction
Colovic M.	-	Premature atherosclerosis in adult growth hormone deficiency: interaction of fibrinolytic and metabolic factors
Colucci M.	-	Identification of a dysfibrinogenemia characterized by marked resistance to fibrinolysis in an asymptomatic woman
Colucci M.	-	Increased procoagulant activity and impaired fibrinolytic potential in blood mononuclear cells after coronary angioplasty for stable or unstable angina
Colucci M.	-	Increased TAFI-dependent anti-fibrinolytic effect associated with the presence of an anti-FV antibody in a patient with severe thrombophilia
	-	Hyperprothrombinemia is associated with enhanced TAFI-mediated inhibition of fibrinolysis
Colwell Jr C. W.	-	Randomized, double-blind comparison of ximelagatran, an oral direct thrombin inhibitor, and warfarin to prevent venous thromboembolism (VTE) after total knee replacement (TKR)
Coma I.	-	Circulating prostaglandin E2 is associated with high risk of coronary heart disease in asymptomatic subjects: a novel inflammatory marker of subclinical atherosclerosis
Combadière C.	-	Fractalkine/CX3CL1 production by human aortic smooth muscle cells impairs monocyte procoagulant and inflammatory responses
Combes V.	-	Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth retardation
Combier C.	-	Standardization of circulating endothelial cell enumeration in whole blood
Combrie R.	-	A deficiency of glycoprotein (GP) VI in platelets of a patient with gray platelet syndrome
Combrié R.	-	Glanzmann thrombasthenia: a study of two Portuguese families and identification of a new homozygous C insertion in exon 10 of the GPIIIa
Comeglio M.	-	New risk factors for coronary artery disease: the endothelial nitric oxide synthase polymorphisms
Comerota A. J.	-	Anti-platelet agents clopidogrel and aspirin inhibit expression of tissue factor procoagulant activity in patients with peripheral artery disease
Comp P. C.	-	Randomized, double-blind comparison of ximelagatran, an oral direct thrombin inhibitor, and warfarin to prevent venous thromboembolism (VTE) after total knee replacement (TKR)
Comp C.	-	A dose–response study of a recombinant human soluble thrombomodulin (ART-123) for prevention of venous thromboembolism after unilateral total hip replacement
Comparetto C.	-	Hemostatic changes in laparoscopic and laparotomic gynecological surgery
Compernolle G.	-	Importance of the mobility of the P' region for conformational and functional changes in PAI-1
Compes M.	-	Mutations in genes of the gamma-glutamyl carboxylase and the vitamin K epoxidase reductase complex are responsible for the phenotype of hereditary combined deficiency of vitamin K-dependent clotting factors
Comrie A.	-	The effect of ABO and Secretor genotypes on thrombin generation
Conard J.	-	Incidence of venous thrombosis in carriers of familial thrombophilia with a personal history of venous thrombosis
Conard J.	-	Risk of pregnancy-related venous thromboembolism (VTE) in 60 hereditary AT-deficient women from 45 families: study of 164 pregnancies
Concolato A.	-	The long-term clinical course of acute deep vein thrombosis of the arm: a prospective cohort study
Conde I.	-	Tissue factor-bearing microparticles arise from monocyte lipid rafts and can fuse with activated platelets, consolidating all of the membrane-bound coagulation reactions on the platelet surface
Conejeros Parodi W.	-	Anticoagulation therapy outcome in children after extracardiac conduit Fontan operation
Conell B.	-	Improved differentiation between factor V wild type and factor V Leiden patients using a new prothrombin-based activated protein C resistance assay
Conkie J. A.	-	Anticardiolipin antibodies and pregnancy outcome: a prospective study in an unselected obstetric population
Conlan M.	-	INTERCEPT platelets, treated to inactivate pathogens, maintain hemostasis in thrombocytopenic patients: results of the SPRINT trial
Conley P. B.	-	P2Y12 regulates platelet adhesion/activation, thrombus growth and thrombus stability in injured arteries
	-	The platelet ADP receptor P2Y12 is a critical player on the pathway of aIIbb3 activation by multiple agonists
Conley P.	-	Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis
Connell S. D.	-	Cross-linking of fibrin by factor XIII and its effect on fibrin structure/function
Connelly P.	-	Inhibition of platelet secretion-induced neutrophil activation by ELR peptide derivatives
Connolly B. L.	-	Central venous catheter-related thrombosis presenting as SVC syndrome in a hemophiliac with inhibitors
Connolly P.	-	Integrin aVb3 dependent adhesion and spreading under shear stress is particular dependent on the two phenylalanines in the highly conserved GFFKR-region
	-	Integrin aVb3 dependent adhesion and spreading under shear stress is particular dependent on the two phenylalanines in the highly conserved GFFKR-region
Connolly B.	-	Central venous catheter (CVC) related thrombosis in boys with hemophilia
	-	Vena cava filters in children: review of a single centre clinical experience over 7 years
Connor D. E.	-	Abciximab therapy post elective coronary artery stenting does not prevent a troponin rise mediated by increased levels of platelet P-selectin and platelet-monocyte aggregates
Connor D.	-	Detection of procoagulants with a more reliable nonactivated clotting test
Connor P.	-	The relationship between APTT and lupus anticoagulants
Connor P.	-	Validation of the Taipan snake venom assay in routine practice to assess lupus anticoagulant status in patients being assessed for lupus anticoagulant and not receiving oral anticoagulant
Connor D.	-	Procoagulant phospholipid in blood normally associates mainly with cells or aggregates larger than microparticles or platelets
Consoli A.	-	NAD(P)H oxidase C242T gene variations and cardiovascular protection
	-	Insulin enhances vascular cell adhesion molecule (VCAM-1) expression in human cultured endothelial cells – a link to the pathogenesis of accelerated atherosclerosis in diabetes
Contarini P.	-	Ligneous conjunctivitis: report of two cases
Contavalli C.	-	Venice DVT
Conti S.	-	Low molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anti-coagulants
Conti A. A.	-	Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
	-	Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
Contu P.	-	Fasting homocysteine levels in predicting post methionine loading test results
Conway E. M.	-	Establishing links between coagulation and inflammation: The lectin-like domain of thrombomodulin confers protection in a murine model of rheumatoid arthritis
Conway D.	-	Increased plasma tissue factor predicts adverse outcome in chronic heart failure
Conway G.	-	Efficacy and safety of low dose vitamin K in outpatient management of patients with an INR > 10
Conway E. M.	-	Endothelial-specific inactivation of survivin in mice results in embryonic lethality with intraembryonic bleeding due to loss of vascular endothelial integrity
Cook D. J. C.	-	Levels of D-dimer do not predict deep venous thrombosis in medical–surgical ICU patients
	-	Baseline thrombophilic markers do not predict deep venous thrombosis in medical–surgical ICU patients
Cook D.	-	Prognostic value of activated protein C levels in patients with severe sepsis
Cooke J.	-	An economic evaluation of the costs and benefits of heparin rationalisation in a UK hospital
Cooke P.	-	A transient factor V inhibitor associated with vasculitis
Cooley B. C.	-	Altered vascular remodeling in hyperfibrinogenemic mice
Cooley B.	-	Opposing effects of P-selectin and PECAM-1 on arterial thrombus growth and stability in vivo
Cooper J. A.	-	Effect of bezafibrate on plasma homocysteine in men with lower extremity arterial disease
Cooper A. V.	-	Fibrinogen gamma chain splice variant (g') alters fibrin structure and function
Cooper P. C.	-	A comparative study of new generation blood sampling tubes for thrombophilia investigations
Cooper J. A.	-	Associations of hemostatic variables with changes in anthropometric measures and metabolic variables in the morbidly obese
	-	C-reactive protein (CRP) may predict death from cancer in men with lower extremity arterial disease
	-	Persistent biochemical hypercoagulability and risk of death from cancer in middle-aged men
	-	The predictive value of C-reactive protein (CRP) for myocardial infarction may be affected by aspirin therapy in men with lower extremity arterial disease
Cooper P. C.	-	Characterization of a new therapeutic recombinant human anti-thrombin concentrate
Cooper S. M.	-	Characterization of a new therapeutic recombinant human anti-thrombin concentrate
Coppell J. A.	-	Combined modality inhibitor eradication in a patient with mild hemophilia A and comparison of methods of inhibitor monitoring
Coppinger J.	-	Proteomic analysis of proteins secreted by platelets
Coppo M.	-	High plasma homocysteine concentrations in cerebrovascular patients with Fabry disease
	-	Homocysteine plasma levels in primary biliary cirrhosis (PBC)
Coppola A.	-	Recombinant activated Factor VII (rFVIIa) for the treatment of bleeding secondary to acquired factor VIII inhibitor
Coppola R.	-	Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarction
	-	Hemostasis and inflammation in advanced heart failure and after successful heart transplantation
Corà F.	-	Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism
Corash L.	-	INTERCEPT platelets, treated to inactivate pathogens, maintain hemostasis in thrombocytopenic patients: results of the SPRINT trial
Corazzi T.	-	Chlamydia pneumoniae seropositivity is associated with increased inflammatory characteristics in atherosclerotic plaques
Corazzi T.	-	Chlamydia pneumoniae seropositivity is associated with increased inflammatory characteristics in atherosclerotic plaques
Corbetta C.	-	A new preanalytical procedure using dried blood spot sample for total homocysteine determination
	-	Triglycerides show an immediate increase during anticoagulant therapy for DVT without increase in thrombin generation
Corbillón L.	-	Glanzmann thrombasthenia: a study of two Portuguese families and identification of a new homozygous C insertion in exon 10 of the GPIIIa
Cordioli G. P.	-	Dental implants in anti-coagulated out-patients
Cordoba A.	-	The PAI-1 and tPA concentrations in patients with classic homocystinuria
	-	The homocysteine, PAI-1 and tPA concentration ratio status: a thrombogenic link in classic homocystinuria
Cordova F.	-	Changes at thromboprophylaxis in a Peruvian hospital from 1996 to 2000
Cordova R.	-	Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study
Cornacchini S.	-	Fasting homocysteine levels in predicting post methionine loading test results
Cornelis M.	-	Individualizing the risk of venous thromboembolism in medical and surgical patients: development of the decision matrix for VTE prophylaxis
Cornelius A.	-	Dramatic improvement in the care and management of patients with DVT in a large UK hospital
Cornelli U.	-	Pharmacodynamics and pharmacokinetics of anti-Xa potency adjusted heparin derived oligosaccharides in nonhuman primates: implications in dosage optimization
	-	Heparin derived oligosaccharides are capable of passing through the blood brain barrier: experimental evidence in a rat model
Corno A. R.	-	VWF:RCo assay implementation on automated coagulometer
Cornuz J.	-	Clinical usefulness of D-dimer according to clinical probability in patients with suspected pulmonary embolism
	-	Clinical usefulness of D-dimer in cancer patients with suspected pulmonary embolism
	-	Diagnosing pulmonary embolism with clinical assessment, d-dimer, venous ultrasound and helical computed tomography: a multicenter management study
Coronel P.	-	Biological effects of sulodexide on hemostatic risk factors of thrombogenesis
	-	Is sulodexide an alternative treatment in the prophylaxis of thromboembolic disease?
Corral J.	-	Conformational basis of homozygous heparin cofactor II deficiency confirms critical role of P17 glutamate in serpins
	-	Mutations in the shutter region of anti-thrombin result in severe episodic thrombosis and unlike other serpins in formation of disulfide-linked dimers
Corral J.	-	Pharmacogenetics in the thrombolytic treatment of myocardial infarction: role of the FXIII V34L polymorphism
Corral J.	-	Detection of conformational transformation of antithrombin in blood by crossed immunoelectrophoresis: new application for a classical method. Effect of temperature in plasmatic antithrombin; role in senescence of antithrombin and thrombosis
	-	Analysis of the HPS-1 gene in patients with single platelet dense-granule deficiency and mild bleeding diathesis
Corral J.	-	Genetic variations of the extra-large stimulatory G protein a-subunit and risk of thrombotic and hemorrhagic disorders
Correa M. E. P.	-	Oral anti-coagulation and dental extraction
Corrocher R.	-	Factor VII polymorphisms and the risk of myocardial infarction in coronary atherosclerosis
	-	Low vitamin B6, markers of inflammation, and coronary artery disease
Corseaux D.	-	Tissue factor pathway in carotid atherosclerotic plaques: relationships with clinical patterns and risk factors
	-	Effect of in vivo thrombin inhibition on bFGF-induced angiogenesis in a murine angiogenic model
Cort S.	-	Malignancy-related thrombotic state is independent of defects in Factor V Leiden, prothrombin 20210 and MTHFR. Results from the initial profiling of cancer patients entering in a secondary prevention of venous thrombosis with enoxaparin (ONCENOX)
	-	Extended thromboprophylaxis with enoxaparin in acutely ill medical patients with prolonged periods of immobilisation: the EXCLAIM study
	-	Secondary prevention of venous thromboembolic events (VTE) in patients with active malignancy: a randomized study of enoxaparin sodium alone vs. initial enoxaparin sodium followed by warfarin for a 180-day period
	-	Non-invasive detection of proximal DVT using bilateral compression ultrasound: methodology for the EXCLAIM study
Cortellaro M.	-	A case of multiorgan atherosclerotic disease in patient affected by hyperhomocystinemia with multiple heterozygous mutations
Cosin J.	-	Insufficient thromboxane A2 inhibition in patients with vascular disease chronically treated with aspirin: implications for platelet function
Cosmi B.	-	Risk of recurrence of venous thromboembolism (VTE) and high factor VIII plasma levels
Cosmi B.	-	D-dimer and residual vein thrombosis assessed at 3 months after anti-coagulation withdrawal are independent risk factors for recurrent venous thromboembolism
	-	Thrombophilia and residual vein thrombosis are independent risk factors for recurrent venous thromboembolism
	-	Markers of inflammation, d-dimer and recurrences after a first episode of venous thromboembolism
	-	The risk of recurrence after a first episode of venous thromboembolism in cancer patients
Cosmi B.	-	Venous thromboembolic complications in patients with multiple myeloma treated with thalidomide:prophylatic effect of fixed dose Wafarin L
Costa M.	-	New automated von Willebrand factor activity assay to distinguish type 1 and type 2 von Willebrand disease (VWD)
Costanzo M.	-	Assessment of platelet function during cardiopulmonary bypass using two new "point of care" devices
	-	Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
	-	Monitoring of heparin therapy during cardiopulmonary bypass by using three different devices that measure the activated clotting time
Cotrina R.	-	Changes at thromboprophylaxis in a Peruvian hospital from 1996 to 2000
Cottell D.	-	Platelet-associated Tissue Factor: modulation of cell surface expression by platelet agonists
Cotter F.	-	Multivariate investigation of determinants of oral anti-coagulant stability
Couban S.	-	A randomized double-blind placebo-controlled study of low dose warfarin for the prevention of symptomatic central venous catheter-associated thrombosis in patients with cancer
Coughlan T.	-	A novel R2464C candidate von Willebrand factor mutation in families with von Willebrand disease
Coughlin S.	-	Protease-activated receptors in vascular biology
Coull A.	-	Markers of hemostatic activation and protein Z in acute stroke and myocardial infarction: a community based pilot study
	-	‘Aspirin resistance’ detected by high shear platelet function testing within the pilot phase of the Oxford Vascular Study (OXVASC)
Coumailleau S.	-	Influence of selective nonpeptide PAR-1 and PAR-4 antagonists on thrombin-induced aggregation of human platelets
Court N.	-	Impact of reagent choice on the APTT response to argatroban
Courtenay B.	-	An evaluation of preoperative hemostatic variables as risk factors for deep venous thrombosis after elective lower limb arthroplasty
	-	A single-center prospective study of clinical and genetic thrombophilic risk factors for deep venous thrombosis (DVT) in 510 patients undergoing elective lower limb surgery
Cousens D. J.	-	Increase in mitogenic and decrease in contractile P2 receptors in smooth muscle cells by fluid shear stress in intact human conduit vessels
Coutinho A.	-	Ischemia/reperfusion induces binding of circulated immunoglobulins to the blood vessels in vivo
Couto L. B.	-	A phase I/II trial of AAV-mediated, liver-directed gene transfer for hemophilia B
Couture P.	-	Asymptomatic venous thrombosis is a frequent event in protein C deficiency: a systematic ultrasound assessment of 208 family members with the 3363-C insertion mutation (IPCI: International Protein C Investigation)
Couty M. C.	-	Comparison of inherited and acquired thrombophilia in cerebral venous thrombosis and pulmonary embolism or deep vein thrombosis of the leg
Covic L.	-	Pepducin-based intervention of platelet signaling and systemic platelet activation
Cowie M.	-	Evidence of transient endothelial activation in patients in sinus rhythm after electrical cardioversion of persistent atrial fibrillation
Cox D.	-	The choice of assay, agonist and anticoagulant for determining efficacy of GPIIb/IIIa antagonists
	-	Evidence for a serum protein mediating Staphylococcus aureus induced platelet aggregation
Cox A.	-	Basal Fibrinogen and FVIII:C Concentrations are not Associated with Polymorphisms in the Interleukin-1 Gene Cluster
Cox L.	-	Complex formation of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) with fibrin(ogen)
Coyne E.	-	Effectiveness of polybrene neutralization of heparin and low-molecular weight heparin in plasma
	-	Activated clotting time guided dosage optimization of a low molecular weight heparin (tinzaparin) for surgical and interventional indications
Cozzi E.	-	Levels of anti-thrombin III activity in the plasma of cynomolgus monkeys after administration of recombinant human anti-thrombin III
	-	Anti-thrombin III levels in cynomolgus monkey recipients of a life-supporting porcine renal xenograft
Cozzi G.	-	In vitro expression study of two naturally occurring mutations (D141Y and C275S) of the von Willebrand factor (VWF) proeptide that result in defective multimerization and secretion
Cozzi M. R.	-	Crucial role of the ADP receptor P2Y1 in platelet adhesion and signaling under high flow
	-	Lagrangian modeling of platelet adhesion and its application to experimental data
Craig S.	-	Improving the quality of INR determination in the anticoagulation clinic
	-	A multicentre assessment of the endogenous thrombin potential using a continuous monitoring amidolytic technique
Craigie S.	-	Inherited thrombophilias are not increased in ‘idiopathic’ small for gestational age pregnancies
Cramer E.	-	Platelets endocytosis of HIV and S. aureus is enhanced by activation and occurs in specific compartment, site of subsequent degranulation
Crane M.	-	Effect of short-term, low-fat vegetarian diet and walking program on coagulation
Cranmer S. L.	-	Cytoskeletal regulation of the adhesive interactions between the platelet GPIb/V/IX receptor and von Willebrand factor
Crapo J.	-	Co-localization of c-AMP-dependent PKA with eNOS in endothelial cell junctions: a clue for regulated NO production
Craven S.	-	Altered regulation of in vivo coagulation in orthopedic patients prior to knee or hip replacement surgery
Craver K. T.	-	A simplified assay for VWF cleaving protease (ADAMTS-13) activity and inhibitor in plasma
Crawley J. T. B.	-	Trafficking and cell surface dynamics of tissue factor pathway inhibitor in living cells
Crawley J.	-	Human endothelial cell protein C receptor (EPCR) expression: role of proximal and distal 5'-gene regulatory elements
Creach O.	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
	-	Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Creagh M. D.	-	A program for the point of care testing (POCT) of the ACT to ensure safe control of heparinization in coronary angioplasty
Crean P.	-	Evaluating 'aspirin resistance' in a population with cardiovascular disease
Crespo F.	-	A sporadic case of gray platelet syndrome
	-	Molecular basis of inherited anti-thrombin deficiency in Portuguese families: identification of underlying molecular defects and screening for additional thrombotic risk factors
Crisler P.	-	The laboratory evaluation of aspirin-resistance in normal, healthy subjects
Cristiani P.	-	Oral anticoagulation telemedicine management system: the MC-SAT project
Crock C.	-	Arterial thromboembolic disease in infants and children
	-	Prospective cohort study of paediatric venous thrombosis
Croft S. A.	-	A new von Willebrand factor (VWF) online mutation and polymorphism database created on behalf of the ISTH VWF scientific and standardization committee (http://www.sheffield.ac.uk/vwf)
Croft S. A.	-	Can full-length wild-type von Willebrand factor (VWF) or the VWF propeptide rescue secretion of the R273W VWF variant associated with quantitative deficiency?
Croppo C.	-	Efficacy of high purity, monoclonal factor IX concentrate for continuous infusion in an hemophilia B patient undergoing orthopedic surgery
	-	Efficacy of high purity, monoclonal factor IX concentrate for continuous infusion in an hemophilia B patient undergoing orthopedic surgery
Crosby T.	-	Effectiveness of polybrene neutralization of heparin and low-molecular weight heparin in plasma
Crosby D.	-	Physical and functional interaction between PKCd and Fyn kinases in human platelets
Crossley M.	-	Protein–protein interaction between Fli-1 and GATA-1 mediates synergistic expression of megakaryocyte-specific genes through cooperative DNA-binding
Crowther M. A.	-	Patients receiving long-term warfarin therapy prefer INR testing with capillary fingerstick over venous blood testing
Crowther M.	-	Levels of D-dimer do not predict deep venous thrombosis in medical–surgical ICU patients
Crowther M.	-	Influence of thrombophilia on efficacy of warfarin for prevention of recurrent venous thromboembolism: results from a randomized trial
Crowther M.	-	Frequency of recurrent thrombosis in patients with antiphospholipid antibodies: a cumulative analysis of prospective trials
	-	Baseline thrombophilic markers do not predict deep venous thrombosis in medical–surgical ICU patients
Crowther M.	-	Ability of d-dimer to reduce the need for diagnostic imaging in patients with suspected pulmonary embolism: A randomized trial
Cuadrado M. J.	-	Increased tissue factor expression in monocytes from patients with anti-phospholipid syndrome depends on NFkB activation
Cucherat M.	-	A systematic review of the accuracy of ultrasound in the diagnosis of asymptomatic deep venous thrombosis: preliminary results
Cuevas B.	-	Biological effects of sulodexide on hemostatic risk factors of thrombogenesis
	-	Is sulodexide an alternative treatment in the prophylaxis of thromboembolic disease?
Cugno M.	-	Activation of the contact system and inflammation after thrombolytic therapy in patients with acute myocardial infarction
Cugno M.	-	Hemostasis and inflammation in advanced heart failure and after successful heart transplantation
Cui D.	-	Terminal intron splicing of the prothrombin premRNA is associated with 3'-cleavage site recognition and polyadenylation
Cullen J.	-	Bleeding phenotype and decreased viability in rap1b knockout mice
Culligan D. J.	-	Plasminogen activators: a feature of normal myeloid differentiation or leukemic transformation?
Culligan K. G.	-	Inhibition of platelet secretion-induced neutrophil activation by ELR peptide derivatives
Cultrera D. C.	-	Desmopressin subcutaneous administration enhances platelet response ‘in vivo’ to Platelet-Activating Factor (PAF) and causes a rise in interleukin-6 plasma levels in haemophilia A and von Willebrand disease type I
Cultrera D.	-	The platelet glycoprotein IIb/IIIa receptor antagonist c7E3Fab inhibits the coagualation activation in patients undergoing to percutaneous transluminal coronary angioplasty (PCTA)
	-	Sickle cell disease, vascular endothelium dysfunction, abnormal endothelin-1 release, interleukin-6 plasma level, hyperhomocysteinaemia and thromboembolic risk
Cumming A.	-	Removing the bottleneck – automated detection of point mutations in the factor VIII gene by fluorescent sequence trace subtraction following high-throughput DNA sequencing
	-	Automated DNA sequencing of the essential regions of the FVIII gene for rapid carrier and prenatal diagnosis in hemophilia A
	-	Type 2M von Willebrand disease: correlation of phenotype with genotype?
Cummins D.	-	Baseline characteristics, risk factor profile and outcomes of patients treated for venous thromboembolic disease with low molecular weight heparin (enoxaparin) – the Venous Thromboembolism Registry (VERITY)
Cung T.	-	Seven novel mutations leading to congenital coagulation factor XIII deficiency
Cunha-Ribeiro L. M.	-	Non-Hodgkin's lymphoma and antiphospholipid antibodies. Are they surrogate markers for relapse?
	-	A different view on the inflammatory bowel disease – the role of adhesion molecules and angiogenic growth factors
	-	Effects of cardiopulmonary bypass on platelet activation markers
	-	Association of MTHFR and ACE gene polymorphisms in reflux associated with renal damage
Cunningham M.	-	MCFD2, a second gene defective in combined factor V/factor VIII deficiency, encodes a novel ER protein that interacts with LMAN1 (ERGIC-53) to form a cofactor-specific sorting receptor
Cunningham A. C.	-	Glycosyl Phosphatidylinositol (GPI)-anchored protein(s) are required for cell surface expression of tissue factor pathway inhibitor (TFPI)
Cunningham M. A.	-	Genetic modifications that increase factor VIII secretion in vitro and in vivo
Cuomo G.	-	Increased intima-media thickness to show relationship between atherosclerosis and inflammation in a human model: patients affected by rheumatoid arthritis and absence of common markers of atherosclerosis
Cuppini S.	-	Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism
Curtin J. A.	-	Warfarin-induced skin necrosis in a child with protein C deficiency and Factor V Leiden mutation
Curtin R.	-	Evaluating 'aspirin resistance' in a population with cardiovascular disease
Curtis R. M.	-	Low molecular weight heparin therapy in neonatal cerebral sinovenous thrombosis: a consecutive cohort study
Curtis B. R.	-	Maternal immunization against ‘rare’ platelet antigens as a cause of neonatal alloimmune thrombocytopenic purpura (NATP)
Curvers J.	-	Storage of apheresis platelets leads to reduced adhesiveness and thrombogenic activity in flowing whole blood ex vivo
Cushman M.	-	The epidemiology of venous thrombosis
Cushman M.	-	Questioning the questionnaire: a sensitivity analysis for data collection on venous thrombosis
Cushman M.	-	C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the Cardiovascular Health Study (CHS)
Cushner F.	-	Prophylactic warfarin in clinical practice. Treatment intensity when warfarin is used to prevent VTE after major joint surgery: findings from the Global Orthopedic Registry (GLORY)
	-	Duration of prophylaxis for venous thromboembolism after total hip and knee arthroplasty: findings from the global orthopedic registry (GLORY)
Cushner F.	-	Concomitant use of mechanical and pharmacological methods of prophylaxis for venous thromboembolism after total hip and knee arthroplasty: Findings from the Global Orthopaedic Registry (GLORY)
Cutler D.	-	Analysis of storage and regulated secretion of three human variants of von Willebrand factor provides new insights into von Willebrand's disease
Cuyun-Lira O.	-	Remnant-like lipoprotein particles potentiate platelet activation under high shear stress assessed by the ‘collagen column’, filled with collagen-coated small beads
	-	Mechanisms of platelet retention in the collagen-coated bead columns
Cvirn G.	-	Increased von-Willebrand-facor-binding to platelets in neonatal plasma
Cvirn G.	-	Low inhibitor levels allow fast and sufficient thrombin generation in tissue factor-activated cord plasma
Czaban S.	-	A prospective analysis of hemostasis in systemic inflammatory response syndrome (SIRS) with acute renal failure
	-	Different pattern of hemostatic abnormalities in infectious and noninfectious systemic inflammatory response syndrome (SIRS)
Czajkowska E.	-	Changes in von Willebrand factor concentration and blood loss during cardiac surgery
Czapek E. E.	-	Type 2 M von Willebrand disease due to linked P1266Q and V1279I substitutions in the von Willebrand factor A1 domain
Czestochowska E.	-	Estimation of plasminogen activator inhibitor type 1 (PAI-1) and plasmin-alpha-2-antiplasmin complex (PAP) serum activities in personal computers operators
Czuriga I.	-	Plasma factor XIII activity, concentration and FXIII-A Val34Leu polymorphism in patients with myocardial infarction and/or coronary sclerosis
Czwalinna A.	-	Expression of Plasminogen activator inhibitor-1 (PAI-1) mRNA in human ciliary processes and determination of PAI-1 in human aqueous humor
	-	A mutation leading to a stop codon in the FVIII gene is the cause of severe canine Hemophilia A
Czwalinna A.	-	New mutations in the fibrinogen genes of patients with dys, hypo- or fibrinogenemia
Czyz A.	-	The influence of Percutaneous Transluminal Coronary Angioplasty (PCTA) in patients with stable angina on the inflammation markers, lymphocyte activation and platelet-leukocyte aggregates in peripheral venous blood
Czyz A.	-	High frequency of combined genetic prothrombotic defects in young patients with ischemic stroke
	-	High frequency of combined genetic prothrombotic defects in young patients with ischemic stroke